<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for weight loss in people with chronic kidney disease who are overweight or obese - Conley, MM - 2021 | Cochrane Library</title> <meta content="Interventions for weight loss in people with chronic kidney disease who are overweight or obese - Conley, MM - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013119.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for weight loss in people with chronic kidney disease who are overweight or obese - Conley, MM - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013119.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013119.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for weight loss in people with chronic kidney disease who are overweight or obese" name="citation_title"/> <meta content="Marguerite M Conley" name="citation_author"/> <meta content="marguerite.conley@health.qld.gov.au" name="citation_author_email"/> <meta content="Catherine M McFarlane" name="citation_author"/> <meta content="Sunshine Coast Hospital and Health Service" name="citation_author_institution"/> <meta content="David W Johnson" name="citation_author"/> <meta content="Princess Alexandra Hospital" name="citation_author_institution"/> <meta content="Jaimon T Kelly" name="citation_author"/> <meta content="Griffith University" name="citation_author_institution"/> <meta content="Katrina L Campbell" name="citation_author"/> <meta content="Griffith University" name="citation_author_institution"/> <meta content="Helen L MacLaughlin" name="citation_author"/> <meta content="Queensland University of Technology" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD013119.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/03/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013119.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013119.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013119.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Blood Pressure; Body Mass Index; Cause of Death; Cholesterol [blood]; Confidence Intervals; Energy Intake; Kidney Failure, Chronic [blood, therapy]; Obesity [blood, complications, therapy]; Overweight [blood, complications, *therapy]; Proteinuria [epidemiology]; Quality of Life; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic [blood, complications, *therapy]; Waist Circumference; *Weight Loss" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013119.pub2&amp;doi=10.1002/14651858.CD013119.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="FKeXZrqu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013119\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013119\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013119.pub2",title:"Interventions for weight loss in people with chronic kidney disease who are overweight or obese",firstPublishedDate:"Mar 30, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013119.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013119.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013119.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013119.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013119.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013119.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013119.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013119.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013119.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013119.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7195 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013119.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0118"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-sec-0112"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/appendices#CD013119-sec-0123"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/table_n/CD013119StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/table_n/CD013119StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for weight loss in people with chronic kidney disease who are overweight or obese </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#CD013119-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Marguerite M Conley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#CD013119-cr-0005">Catherine M McFarlane</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#CD013119-cr-0006">David W Johnson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#CD013119-cr-0007">Jaimon T Kelly</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#CD013119-cr-0008">Katrina L Campbell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information#CD013119-cr-0009">Helen L MacLaughlin</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information/en#CD013119-sec-0130">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 March 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013119.pub2">https://doi.org/10.1002/14651858.CD013119.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013119-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013119-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013119-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013119-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013119-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013119-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013119-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013119-abs-0001" lang="en"> <section id="CD013119-sec-0001"> <h3 class="title" id="CD013119-sec-0001">Background</h3> <p>Obesity and chronic kidney disease (CKD) are highly prevalent worldwide and result in substantial health care costs. Obesity is a predictor of incident CKD and progression to kidney failure. Whether weight loss interventions are safe and effective to impact on disease progression and clinical outcomes, such as death remains unclear. </p> </section> <section id="CD013119-sec-0002"> <h3 class="title" id="CD013119-sec-0002">Objectives</h3> <p>This review aimed to evaluate the safety and efficacy of intentional weight loss interventions in overweight and obese adults with CKD; including those with end‐stage kidney disease (ESKD) being treated with dialysis, kidney transplantation, or supportive care. </p> </section> <section id="CD013119-sec-0003"> <h3 class="title" id="CD013119-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Register of Studies up to 14 December 2020 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. </p> </section> <section id="CD013119-sec-0004"> <h3 class="title" id="CD013119-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and quasi‐RCTs of more than four weeks duration, reporting on intentional weight loss interventions, in individuals with any stage of CKD, designed to promote weight loss as one of their primary stated goals, in any health care setting. </p> </section> <section id="CD013119-sec-0005"> <h3 class="title" id="CD013119-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed study eligibility and extracted data. We applied the Cochrane 'Risk of Bias' tool and used the GRADE process to assess the certainty of evidence. We estimated treatment effects using random‐effects meta‐analysis. Results were expressed as risk ratios (RR) for dichotomous outcomes together with 95% confidence intervals (CI) or mean differences (MD) or standardised mean difference (SMD) for continuous outcomes or in descriptive format when meta‐analysis was not possible. </p> </section> <section id="CD013119-sec-0006"> <h3 class="title" id="CD013119-sec-0006">Main results</h3> <p>We included 17 RCTs enrolling 988 overweight or obese adults with CKD. The weight loss interventions and comparators across studies varied. We categorised comparisons into three groups: any weight loss intervention versus usual care or control; any weight loss intervention versus dietary intervention; and surgical intervention versus non‐surgical intervention. Methodological quality was varied, with many studies providing insufficient information to accurately judge the risk of bias. Death (any cause), cardiovascular events, successful kidney transplantation, nutritional status, cost effectiveness and economic analysis were not measured in any of the included studies. Across all 17 studies many clinical parameters, patient‐centred outcomes, and adverse events were not measured limiting comparisons for these outcomes. </p> <p>In studies comparing any weight loss intervention to usual care or control, weight loss interventions may lead to weight loss or reduction in body weight post intervention (6 studies, 180 participants: MD ‐3.69 kg, 95% CI ‐5.82 to ‐1.57; follow‐up: 5 weeks to 12 months, very low‐certainty evidence). In very low certainty evidence any weight loss intervention had uncertain effects on body mass index (BMI) (4 studies, 100 participants: MD ‐2.18 kg/m², 95% CI ‐4.90 to 0.54), waist circumference (2 studies, 53 participants: MD 0.68 cm, 95% CI ‐7.6 to 6.24), proteinuria (4 studies, 84 participants: 0.29 g/day, 95% CI ‐0.76 to 0.18), systolic (4 studies, 139 participants: ‐3.45 mmHg, 95% CI ‐9.99 to 3.09) and diastolic blood pressure (4 studies, 139 participants: ‐2.02 mmHg, 95% CI ‐3.79 to 0.24). Any weight loss intervention made little or no difference to total cholesterol, high density lipoprotein cholesterol, and inflammation, but may lower low density lipoprotein cholesterol. </p> <p>There was little or no difference between any weight loss interventions (lifestyle or pharmacological) compared to dietary‐only weight loss interventions for weight loss, BMI, waist circumference, proteinuria, and systolic blood pressure, however diastolic blood pressure was probably reduced. Furthermore, studies comparing the efficacy of different types of dietary interventions failed to find a specific dietary intervention to be superior for weight loss or a reduction in BMI. </p> <p>Surgical interventions probably reduced body weight (1 study, 11 participants: MD ‐29.50 kg, 95% CI ‐36.4 to ‐23.35), BMI (2 studies, 17 participants: MD ‐10.43 kg/m², 95% CI ‐13.58 to ‐7.29), and waist circumference (MD ‐30.00 cm, 95% CI ‐39.93 to ‐20.07) when compared to non‐surgical weight loss interventions after 12 months of follow‐up. Proteinuria and blood pressure were not reported. </p> <p>All results across all comparators should be interpreted with caution due to the small number of studies, very low quality of evidence and heterogeneity across interventions and comparators. </p> </section> <section id="CD013119-sec-0007"> <h3 class="title" id="CD013119-sec-0007">Authors' conclusions</h3> <p>All types of weight loss interventions had uncertain effects on death and cardiovascular events among overweight and obese adults with CKD as no studies reported these outcome measures. Non‐surgical weight loss interventions (predominately lifestyle) appear to be an effective treatment to reduce body weight, and LDL cholesterol. Surgical interventions probably reduce body weight, waist circumference, and fat mass. The current evidence is limited by the small number of included studies, as well as the significant heterogeneity and a high risk of bias in most studies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013119-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013119-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013119-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013119-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013119-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013119-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013119-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013119-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013119-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013119-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013119-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013119-abs-0007">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013119-abs-0002" lang="en"> <h3>Weight loss interventions for people with chronic kidney disease who are overweight or obese </h3> <p><b>What is the issue?</b> </p> <p>People who are overweight or obese with chronic kidney disease (CKD) may experience a faster progression to kidney failure than those who are a healthy weight. Some people with more advanced kidney disease may require treatment such as dialysis or a kidney transplant. Being obese can make these treatments difficult and may increase a person's risk of health complications. There is limited research looking at whether weight loss interventions are safe and beneficial to help people with CKD lose weight, improve their kidney function, and live longer. </p> <p><b>What did we do?</b> </p> <p>We conducted a review of the literature to examine the benefits of weight loss interventions for people with CKD who are overweight or obese. </p> <p><b>What did we find?</b> </p> <p>We identified 17 studies involving 988 overweight or obese adults with CKD looking at whether weight loss interventions improved their health. Studies included adults with CKD stages 1 to 4 or kidney transplant recipients. None of the studies included participants who were undergoing dialysis or supportive care. Weight loss interventions included weight loss diets, physical activity programs, drugs to suppress appetite, and weight loss surgery. The main outcomes we were interested in were death, cardiovascular events, weight loss, body mass index (BMI), waist circumference, protein in the urine (proteinuria), and blood pressure (BP). </p> <p>After combining the available studies, its uncertain whether weight loss interventions helped people live longer or prevented cardiovascular events such as heart complications or stroke as none of the included studies measured these outcomes. We found when compared to no weight loss interventions, weight loss interventions may lead to more weight loss. There were little or no differences seen in BMI, waist circumference, proteinuria, or BP. We found that weight loss surgery achieved more weight loss than non‐surgical interventions. However, many of the studies included in this review were limited by small participant numbers, high risk of bias and inconsistent reporting of outcome measures leading to the overall quality of the evidence to be very low. This means that we cannot be sure that future studies would find similar results. </p> <p><b>Conclusions</b> </p> <p>The evidence is not very certain but suggests that compared with usual care or control those who participated in weight loss interventions may experience some health benefits including improvements in body weight. Whether these benefits help reduce cardiovascular outcomes and the risk of death remains uncertain and require further study. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013119-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013119-sec-0118"></div> <h3 class="title" id="CD013119-sec-0119">Implications for practice</h3> <section id="CD013119-sec-0119"> <p>In the context of mild to moderate CKD, and post kidney transplantation, lifestyle‐based weight loss interventions may result in weight loss and may have positive effects on DBP and LDL cholesterol. No particular dietary intervention was superior to another; therefore it is likely that energy deficit remains key, and dietary interventions or mixed lifestyle interventions demonstrated more positive effects that exercise interventions alone. Evidence from RCTs for interventions using surgical interventions is lacking. We are unable to say whether weight loss interventions have an effect on proteinuria, CrCl or measured GFR. </p> <p>Presently, it is recommended that the selection of weight loss interventions should be individualised, based not only on an assessment of the risks and benefits of individual weight loss intervention procedures and the level of kidney function, but also in combination with thorough consideration of patient preferences, motivations, confidence, and previous experience with weight loss interventions. </p> </section> <h3 class="title" id="CD013119-sec-0120">Implications for research</h3> <section id="CD013119-sec-0120"> <p>Long‐term RCTs assessing the effect of intentional weight loss interventions (lifestyle, pharmacological and surgical) on death, cardiovascular events and on kidney outcomes such as measured GFR, CKD progression, development of ESKD, and successful transplantation in people with all stages of kidney disease are needed. It is also important that all future studies in this area are designed to and report on a standardised set of clinical, patient‐centred, economic and safety outcome measures including reporting on mean difference of these outcome measures so that future meta‐analysis can be conducted with a higher level and certainty of evidence. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013119-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013119-sec-0008"></div> <div class="table" id="CD013119-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any weight loss intervention compared to usual care or control</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Any weight loss intervention versus usual care/control for weight loss in people with chronic kidney disease (CKD) who are overweight or obese</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with CKD who are overweight or obese<br/><b>Setting:</b> various (hospital outpatient clinic, research organisation)<br/><b>Intervention:</b> any weight loss intervention<br/><b>Comparison:</b> usual care or control </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with usual care/control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with weight loss intervention</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (any cause)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported by any of the included studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported by any of the included studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Weight loss</b><br/>Follow up: range 5 weeks to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean weight loss ranged across control groups from 0.3 to 0.7 kg; mean post intervention body weight ranged from 86 to 136 kg </p> <p>The mean weight loss in the intervention group was 3.69 kg lower than the control group (5.82 lower to 1.57 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>180 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Majority of studies from lifestyle interventions</p> <p>No studies involving surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Body mass index (BMI)</b><br/>Follow up: range 3 to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean BMI across control groups ranged from 28 to 38 kg/m²</p> <p>The mean BMI in the intervention group was 2.18 kg/m² lower than the control group<br/>(4.90 lower to 0.54 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Waist circumference</b><br/>Follow up: range 3 to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean waist circumference across control groups ranged from 96 to 103 cm</p> <p>The mean weight circumference in the intervention group was 0.68 cm lower than the control group (7.6 lower to 6.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proteinuria</b><br/>Follow up: range 3 to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean proteinuria across control groups ranged from 0.5 to 3.5 g/day</p> <p>The mean proteinuria in the intervention group was 0.29 g/day lower than the control group (0.76 lower to 0.18 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Systolic blood pressure (SBP)</b><br/>Follow up: range 3 to 6 months </p> <p><b>Diastolic blood pressure (DBP)</b><br/>Follow up: range 3 to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean SBP across control groups ranged from 123 to 140 mmHg</p> <p>The mean SBP in the intervention group was ‐3.45 mmHg lower than the control group (‐9.99 lower to 3.09 higher) </p> <p>The mean DBP across control groups ranged from 75 to 89 mmHg</p> <p>The mean DBP in the intervention group was ‐2.02 mmHg lower than the control group (‐3.79 lower to 0.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>139 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Evidence certainty downgraded one level for indirectness </p> <p><sup>2</sup> Evidence certainty downgraded one level for imprecision </p> <p><sup>3</sup> Evidence certainty downgraded one level for uncertain or high risk of bias </p> <p><sup>4</sup> Evidence certainty downgraded one level for moderate heterogeneity </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013119-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013119-sec-0009"></div> <section id="CD013119-sec-0010"> <h3 class="title" id="CD013119-sec-0010">Description of the condition</h3> <p>Obesity and chronic kidney disease (CKD) are highly prevalent worldwide and result in substantial healthcare burdens. Overweight and obesity are defined as ''abnormal or excessive fat accumulation that presents a risk to health'' and are commonly defined by a measure of body mass index (BMI) (<a href="./references#CD013119-bbs2-0063" title="World Health Organization. Obesity and overweight. who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (accessed 17 February 2021).">WHO 2017</a>). A BMI of &gt; 25 kg/m² is considered overweight and a BMI &gt; 30 kg/m² is considered obese. Since 1980, worldwide obesity has almost doubled and approximately 39% of adults are now overweight and 13% are obese (<a href="./references#CD013119-bbs2-0063" title="World Health Organization. Obesity and overweight. who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (accessed 17 February 2021).">WHO 2017</a>). In 2015, an increased BMI accounted for around 4 million deaths and 120 million disability‐adjusted life years (DALYs) worldwide (<a href="./references#CD013119-bbs2-0034" title="GBD 2015 Obesity Collaborators, AfshinA , ForouzanfarMH , ReitsmaMB , SurP , EstepK , et al. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine2017;377(1):13-27. [MEDLINE: 28604169]">Afshin 2017</a>). </p> <p>CKD is defined as “kidney damage for ≥ 3 months, as defined by structural or functional abnormalities of the kidney, with or without decreased glomerular filtration rate (GFR) or GFR &lt; 60 mL/min/1.73 m² for ≥ 3 months, with or without kidney damage” (<a href="./references#CD013119-bbs2-0049" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2013</a>). CKD is categorised into five stages, with the fifth stage, end‐stage kidney disease (ESKD) requiring kidney replacement therapy (KRT) for survival (<a href="./references#CD013119-bbs2-0049" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2013</a>). An estimated 11% to 13% of adults worldwide have CKD with the prevalence steadily increasing (<a href="./references#CD013119-bbs2-0048" title="HillNR , FatobaST , OkeJL , HirstJA , O'CallaghanCA , LassersonDS , et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS ONE [Electronic Resource]2016;11(7):e0158765. [MEDLINE: 27383068]">Hill 2016</a>). All stages of CKD have an increased risk of cardiovascular disease (CVD), increased death and poorer quality of life (<a href="./references#CD013119-bbs2-0060" title="van derVeldeM , MatsushitaK , CoreshJ , AstorBC , WoodwardM , LeveyAS , et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality: a collaborative meta-analysis of high-risk population cohorts. Kidney International2011;79(12):1341-52. [MEDLINE: 21307840]">van der Velde 2011</a>; <a href="./references#CD013119-bbs2-0062" title="WeinerDE , TighiouartH , AminMG , StarkPC , MacLeodB , GriffithJL , et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Journal of the American Society of Nephrology2004;15(5):1307-15. [MEDLINE: 15100371]">Weiner 2004</a>). Global death rates for CKD rose by 41% between the years 1990 to 2016 (<a href="./references#CD013119-bbs2-0041" title="Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2016. Results. ghdx.healthdata.org/gbd-2016 (accessed 17 February 2021).">GBD 2016</a>) and CKD is now the 13th leading male and 11th leading female risk of DALYs (<a href="./references#CD013119-bbs2-0042" title="GBD 2016 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [Erratum in: Lancet. 2017 Oct 14;390(10104):1736; PMID: 28935160; Erratum in: Lancet. 2017 Oct 28;390(10106):e38; PMID: 29032996]. Lancet2017;390(10100):1345-422. [MEDLINE: 28919119]">GBD 2017</a>) and accounts for 25% of all BMI‐related DALYs (<a href="./references#CD013119-bbs2-0034" title="GBD 2015 Obesity Collaborators, AfshinA , ForouzanfarMH , ReitsmaMB , SurP , EstepK , et al. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine2017;377(1):13-27. [MEDLINE: 28604169]">Afshin 2017</a>). </p> <p>Obesity is considered a strong predictor of new onset of CKD and progression to ESKD (<a href="./references#CD013119-bbs2-0050" title="KovesdyCP , FurthSL , ZoccaliC , World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. Kidney International2017;91(2):260–2. [MEDLINE: 28010887]">Kovesdy 2017</a>; <a href="./references#CD013119-bbs2-0059" title="TsujimotoT , SairenchiT , IsoH , IrieF , YamagishiK , WatanabeH , et al. The dose-response relationship between body mass index and the risk of incident stage &gt;=3 chronic kidney disease in a general Japanese population: the Ibaraki prefectural health study (IPHS). Journal of Epidemiology2014;24(6):444–51. [MEDLINE: 24998954]">Tsujimoto 2014</a>). In the general population, compared to those of a healthy weight (BMI of 20to 25 kg/m²), obese adults with a BMI ≥ 35 kg/m² are at a 122% increased risk of developing of ESKD (<a href="./references#CD013119-bbs2-0045" title="HerringtonWG , SmithM , BankheadC , MatsushitaK , StevensS , HoltT , et al. Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS ONE [Electronic Resource]2017;12(3):e0173515. [MEDLINE: 28273171]">Herrington 2017</a>). Obesity increases the risk of developing diabetes and hypertension, which are the two leading causes of CKD. Furthermore, in obese individuals, a compensatory hyperfiltration occurs to meet the increased metabolic demands of the higher body weight (<a href="./references#CD013119-bbs2-0040" title="DarouichS , GouchaR , JaafouraMH , ZekriS , Ben MaizH , KhederA . Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastructural Pathology2011;35(4):176-82. [MEDLINE: 21657818]">Darouich 2011</a>). The ensuing increase in intraglomerular pressure can damage the kidneys and raise the risk of developing CKD in the long term. For those who reach ESKD, obesity adversely affects eligibility for kidney transplantation (<a href="./references#CD013119-bbs2-0051" title="LadhaniM , CraigJC , IrvingM , ClaytonP , WongG . Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrology Dialysis Transplantation2017;32(3):439-49. [MEDLINE: 27190330]">Ladhani 2017</a>), with morbidly obese patients 44% less likely to receive a donor kidney (<a href="./references#CD013119-bbs2-0057" title="SegevDL , SimpkinsCE , ThompsonRE , LockeJE , WarrenDS , MontgomeryRA . Obesity impacts access to kidney transplantation. Journal of the American Society of Nephrology2008;19(2):349-55. [MEDLINE: 18094366]">Segev 2008</a>). </p> <p>A recent systematic review exploring the association between obesity and cardiovascular morbidity and death in CKD (<a href="./references#CD013119-bbs2-0051" title="LadhaniM , CraigJC , IrvingM , ClaytonP , WongG . Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrology Dialysis Transplantation2017;32(3):439-49. [MEDLINE: 27190330]">Ladhani 2017</a>), highlighted that obesity (defined by BMI) may be protective for death (any cause) in the predialysis and haemodialysis (HD) populations, but not in peritoneal dialysis (PD) or transplant recipients. This relationship however is unlikely to be linear, with the highest risk of death occurring at extreme BMI categories. The biological rationale for the obesity paradox across different CKD stages remains unclear. It is proposed that obesity may lead to improved stem cell mobilisation, better bone strength, improved haemodynamic tolerance, and preserved energy stores (<a href="./references#CD013119-bbs2-0058" title="StenvinkelP , LindholmB . Resolved: being fat is good for dialysis patients. The godzilla effect: con. Journal of the American Society of Nephrology2008;19(6):102-4. [MEDLINE: 18512270]">Stenvinkel 2008</a>). However the relationship remains complex and is likely confounded by a number of factors including muscle mass, life expectancy, co‐morbidities, nutritional status, and measurement of obesity (<a href="./references#CD013119-bbs2-0051" title="LadhaniM , CraigJC , IrvingM , ClaytonP , WongG . Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrology Dialysis Transplantation2017;32(3):439-49. [MEDLINE: 27190330]">Ladhani 2017</a>; <a href="./references#CD013119-bbs2-0058" title="StenvinkelP , LindholmB . Resolved: being fat is good for dialysis patients. The godzilla effect: con. Journal of the American Society of Nephrology2008;19(6):102-4. [MEDLINE: 18512270]">Stenvinkel 2008</a>). These conflicting data demonstrate gaps in our current understanding of the links between obesity, kidney disease and clinical outcomes. Accordingly, this places emphasis on evaluating the safety and efficacy of weight loss interventions in obese or overweight patients with CKD (of various stages). </p> </section> <section id="CD013119-sec-0011"> <h3 class="title" id="CD013119-sec-0011">Description of the intervention</h3> <p>This review focused on interventions designed to promote intentional weight loss to improve patient outcomes. Weight loss interventions are typically aimed towards reducing an individual’s energy intake and/or increasing daily energy expenditure in order to induce weight loss, and can be broadly classified into lifestyle, pharmacological and surgical interventions. Lifestyle interventions included those exploring diet, physical activity, exercise, or behavioural strategies used in isolation or in combination to reduce energy intake and/or increase energy expenditure. Pharmacological interventions included interventions using drugs, which reduce absorption or suppress appetite. Surgical interventions included restrictive surgery designed to limit food intake (i.e. gastric banding or sleeve gastrectomy) or cause malabsorption (i.e. intestinal bypass) or both (i.e. gastric bypass). This review included these interventions used alone or in combination. </p> </section> <section id="CD013119-sec-0012"> <h3 class="title" id="CD013119-sec-0012">How the intervention might work</h3> <p>Both surgical and non‐surgical weight loss interventions have been explored in CKD patients, and may play an important role in slowing the progression of CKD and its associated risk factors; diabetes, hypertension, dyslipidaemia, and CVD (<a href="./references#CD013119-bbs2-0036" title="AshS , CampbellK , MacLaughlinH , McCoyE , ChanM , AndersonK , et al. Evidence based practice guidelines for the nutritional management of chronic kidney disease. Nutrition &amp; Dietetics2006;63(s2):S35-45. [DOI: 10.1111/j.1747-0080.2006.00100.x]">Ash 2006</a>). While both weight loss interventions result in reductions in BMI, the magnitude is greater in those receiving surgical intervention (<a href="./references#CD013119-bbs2-0037" title="BolignanoD , ZoccaliC . Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrology Dialysis Transplantation2013;28 Suppl 4:iv82-98. [MEDLINE: 24092846]">Bolignano 2013</a>; <a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a>). Non‐surgical interventions have proven to be a successful and cost effective therapy in the CKD population; demonstrating short‐term weight reduction and corresponding improvements in systolic blood pressure (SBP), lipid profile and proteinuria (<a href="./references#CD013119-bbs2-0037" title="BolignanoD , ZoccaliC . Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrology Dialysis Transplantation2013;28 Suppl 4:iv82-98. [MEDLINE: 24092846]">Bolignano 2013</a>; <a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a>). However in practice many people are unable to maintain lifestyle change and regain lost body weight. Consequently these interventions may fail to achieve sustained weight loss, reductions in cardiorenal and metabolic risks and induce sufficient weight loss for transplant consideration in many obese patients (<a href="./references#CD013119-bbs2-0062" title="WeinerDE , TighiouartH , AminMG , StarkPC , MacLeodB , GriffithJL , et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Journal of the American Society of Nephrology2004;15(5):1307-15. [MEDLINE: 15100371]">Weiner 2004</a>). Bariatric surgery is currently considered the most effective weight loss intervention to achieve long‐term weight loss in morbidly obese individuals (<a href="./references#CD013119-bbs2-0039" title="ColquittJL , PickettK , LovemanE , FramptonGK . Surgery for weight loss in adults. Cochrane Database of Systematic Reviews2014, Issue 8. Art. No: CD003641. [DOI: 10.1002/14651858.CD003641.pub4]">Colquitt 2014</a>); and has been evaluated in obese individuals with CKD as an approach to achieve sustained weight loss and examine kidney function (<a href="./references#CD013119-bbs2-0038" title="ChangAR , GramsME , NavaneethanSD . Bariatric surgery and kidney related outcomes. KI Reports2017;2(2):261-70. [MEDLINE: 28439568]">Chang 2017</a>). Evidence from observational studies have shown that weight loss achieved through bariatric surgery can reduce the effects of CKD by reducing glomerular hyperfiltration, proteinuria, albuminuria, blood pressure (BP), hyperglycaemia and may induce diabetes remission (<a href="./references#CD013119-bbs2-0037" title="BolignanoD , ZoccaliC . Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrology Dialysis Transplantation2013;28 Suppl 4:iv82-98. [MEDLINE: 24092846]">Bolignano 2013</a>; <a href="./references#CD013119-bbs2-0038" title="ChangAR , GramsME , NavaneethanSD . Bariatric surgery and kidney related outcomes. KI Reports2017;2(2):261-70. [MEDLINE: 28439568]">Chang 2017</a>). This may have important clinical applications as early bariatric surgery may assist with reversal of diabetes, hypertension and glomerular hyperfiltration possibly preventing further kidney injury. This may delay the need for KRT, open up opportunities for kidney transplantation and decrease the significant health burden associated with obesity and CKD. </p> </section> <section id="CD013119-sec-0013"> <h3 class="title" id="CD013119-sec-0013">Why it is important to do this review</h3> <p>The incidences of obesity and CKD continue to escalate and are contributing to more global death, morbidity, disability, and healthcare cost than ever before (<a href="./references#CD013119-bbs2-0048" title="HillNR , FatobaST , OkeJL , HirstJA , O'CallaghanCA , LassersonDS , et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS ONE [Electronic Resource]2016;11(7):e0158765. [MEDLINE: 27383068]">Hill 2016</a>). Whether weight loss can reverse these impacts however remains unclear and few practice guidelines exist regarding appropriate strategies for weight management in people with CKD (<a href="./references#CD013119-bbs2-0052" title="LambertK , BeerJ , DumontR , HewittK , ManleyK , MeadeA , et al. Weight management strategies for those with chronic kidney disease - a consensus report from the Asia Pacific Society of Nephrology and Australia and New Zealand Society of Nephrology 2016 renal dietitians meeting. Nephrology2017;23(10):912-20. [MEDLINE: 28742255]">Lambert 2017</a>). Reducing and managing obesity may reverse or slow CKD progression and enable transplantation as a treatment option for more individuals (<a href="./references#CD013119-bbs2-0038" title="ChangAR , GramsME , NavaneethanSD . Bariatric surgery and kidney related outcomes. KI Reports2017;2(2):261-70. [MEDLINE: 28439568]">Chang 2017</a>; <a href="./references#CD013119-bbs2-0053" title="LassalleM , FezeuLK , CouchoudC , HannedoucheT , MassyZA , CzernichowS . Obesity and access to kidney transplantation in patients starting dialysis: a prospective cohort study. PLoS ONE [Electronic Resource]2017;12(5):e0176616. [MEDLINE: 28493926]">Lassalle 2017</a>). However, weight loss interventions in people with CKD are not without risk. Lifestyle interventions such as very low energy diets may cause electrolyte disturbances, fluid overload, constipation, uraemia, and blood glucose disturbances in those with diabetes (<a href="./references#CD013119-bbs2-0052" title="LambertK , BeerJ , DumontR , HewittK , ManleyK , MeadeA , et al. Weight management strategies for those with chronic kidney disease - a consensus report from the Asia Pacific Society of Nephrology and Australia and New Zealand Society of Nephrology 2016 renal dietitians meeting. Nephrology2017;23(10):912-20. [MEDLINE: 28742255]">Lambert 2017</a>). Weight loss medication such as lipase inhibitors may cause steatorrhoea, abdominal pain, flatulence, and increase the risk of oxalate nephropathy and kidney stones (<a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a>). Surgical interventions may be associated with higher rates of complications, such as band erosion, gastric leak and acute kidney injury (AKI) when compared with the non‐CKD population and surgeries featuring malabsorption appear to increase the risk of nephrolithiasis and oxalate nephropathy (<a href="./references#CD013119-bbs2-0038" title="ChangAR , GramsME , NavaneethanSD . Bariatric surgery and kidney related outcomes. KI Reports2017;2(2):261-70. [MEDLINE: 28439568]">Chang 2017</a>; <a href="./references#CD013119-bbs2-0062" title="WeinerDE , TighiouartH , AminMG , StarkPC , MacLeodB , GriffithJL , et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Journal of the American Society of Nephrology2004;15(5):1307-15. [MEDLINE: 15100371]">Weiner 2004</a>). Furthermore highly restrictive diets post bariatric surgery can lead to dietary intakes well below recommended daily nutrient targets increasing risk of long‐term nutrient deficiencies (<a href="./references#CD013119-bbs2-0039" title="ColquittJL , PickettK , LovemanE , FramptonGK . Surgery for weight loss in adults. Cochrane Database of Systematic Reviews2014, Issue 8. Art. No: CD003641. [DOI: 10.1002/14651858.CD003641.pub4]">Colquitt 2014</a>). This systematic review aimed to provide a current and comprehensive review of weight reduction interventions in CKD by including both overweight and obese adults at all stages of CKD (including pre dialysis, dialysis, supportive care, or kidney transplantation). This will provide a better understanding of the balance of benefits and harms of weight loss in CKD which will help better inform clinical decision‐making by clinicians, patients, and their caregivers. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013119-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013119-sec-0014"></div> <p>This review aimed to evaluate the safety and efficacy of intentional weight loss interventions in overweight and obese adults with CKD; including those with ESKD being treated with dialysis, kidney transplantation, or supportive care. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013119-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013119-sec-0015"></div> <section id="CD013119-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013119-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) and quasi RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) looking at the efficacy of intentional weight loss interventions in adults with CKD. </p> </section> <section id="CD013119-sec-0018"> <h4 class="title">Types of participants</h4> <section id="CD013119-sec-0019"> <h5 class="title">Inclusion criteria</h5> <p>Adults who were overweight (as defined by BMI 25 kg/m² to 29.9 kg/m²) or obese (as defined by BMI ≥ 30 kg/m²) (<a href="./references#CD013119-bbs2-0063" title="World Health Organization. Obesity and overweight. who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (accessed 17 February 2021).">WHO 2017</a>) with pre‐existing CKD defined by the Kidney Disease: Improving Global Outcomes (<a href="./references#CD013119-bbs2-0049" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2013</a>) "kidney damage for ≥ 3 months, as defined by structural or functional abnormalities of the kidney, with or without decreased GFR, or GFR &lt; 60 mL/min/1.73m² for ≥ 3 months, with or without kidney damage". The review included individuals with CKD or ESKD treated with dialysis (both HD and PD), kidney transplantation, or supportive care. </p> <p>Subgroup data from studies who had participants meeting our inclusion criteria were included in the review if data were available for those who met the inclusion criteria. In studies where subgroup data for those who met the inclusion was not available, if &gt; 75% of participants met the inclusion criteria then the study with the whole group analysis were included in the review. </p> </section> <section id="CD013119-sec-0020"> <h5 class="title">Exclusion criteria</h5> <p>The review excluded studies involving pregnant women, children (younger than 18 years) and people with an AKI. </p> </section> </section> <section id="CD013119-sec-0021"> <h4 class="title">Types of interventions</h4> <p>We investigated studies reporting on intentional weight loss interventions of at least four weeks in duration, designed to promote weight loss as one of their primary stated goals, in any health care setting. </p> <p>These studies included:</p> <p> <ul id="CD013119-list-0001"> <li> <p>Lifestyle interventions, including dietary interventions (i.e. energy restricted diet, very low energy dense diet), physical activity interventions (i.e. aerobic exercise, resistance exercise, group exercise programs), behavioural change interventions (strategies to assist with lifestyle modification i.e. self‐monitoring of eating habits, stress management), and combination lifestyle interventions (using any combination of diet, exercise and/or behavioural interventions) </p> </li> <li> <p>Pharmacological interventions, including appetite suppressants, drugs that cause fat malabsorption of any dose and route, pharmacological plus lifestyle interventions. </p> </li> <li> <p>Surgical interventions, including sleeve gastrectomy, gastric banding, or bypass procedure</p> </li> </ul> </p> <p>We planned to compare any of these interventions with any other intervention, placebo, or usual care. The comparisons separated by intervention type were as follows: </p> <p> <ol id="CD013119-list-0002"> <li> <p>Any weight loss intervention versus usual care or control (main comparison)</p> </li> <li> <p>Any weight loss intervention versus dietary intervention and</p> </li> <li> <p>Surgical intervention versus non‐surgical intervention</p> </li> </ol> </p> </section> <section id="CD013119-sec-0022"> <h4 class="title">Types of outcome measures</h4> <section id="CD013119-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013119-list-0003"> <li> <p>Death (any cause)</p> </li> <li> <p>Cardiovascular events</p> </li> <li> <p>Anthropometric measures (weight loss, body weight, BMI, waist circumference, waist‐to‐hip ratio, and body composition) </p> </li> </ul> </p> </section> <section id="CD013119-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p>1. Clinical parameters</p> <p> <ul id="CD013119-list-0004"> <li> <p>Kidney function measures: measured GFR, creatinine clearance (CrCl), serum creatinine (SCr), proteinuria, albuminuria, glomerular hyperfiltration (as defined and measured by study investigators). These parameters were assessed in participants with CKD stages 1 to 4 and those who have had a kidney transplant. These parameters were not assessed in participants undergoing dialysis. </p> </li> <li> <p>BP: SBP and diastolic (DBP), anti‐hypertensive medication changes</p> </li> <li> <p>Blood glucose: glycosylated haemoglobin (HbA1c), fasting blood glucose, hypoglycaemic medication changes </p> </li> <li> <p>Lipid profile: total cholesterol, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides, lipid lowering medication changes </p> </li> <li> <p>Successful kidney transplantation</p> </li> <li> <p>Inflammation (C‐reactive protein).</p> </li> </ul> </p> <p>2. Patient‐centred outcomes using validated tools or self‐reported data</p> <p> <ul id="CD013119-list-0005"> <li> <p>Adherence to treatment</p> </li> <li> <p>Health‐related quality of life (HRQoL)</p> </li> <li> <p>Nutritional status</p> </li> <li> <p>Dietary intake</p> </li> <li> <p>Physical activity behaviours.</p> </li> </ul> </p> <p>3. Cost effectiveness and economic analysis</p> <p> <ul id="CD013119-list-0006"> <li> <p>Cost per DALYs or quality‐adjusted life year (QALY)</p> </li> <li> <p>Cost associated with weight loss intervention.</p> </li> </ul> </p> <p>4. Adverse events and potential harms</p> <p> <ul id="CD013119-list-0007"> <li> <p>Hospitalisation</p> </li> <li> <p>Adverse patient outcomes associated with each weight loss intervention</p> </li> <li> <p>Biochemical adverse effects such as hyperkalaemia or hyperphosphataemia.</p> </li> </ul> </p> </section> </section> </section> <section id="CD013119-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013119-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Specialised Register</a> up to 14 December 2020 through contact with the Information Specialist using search terms relevant to this review. The Cochrane Kidney and Transplant Specialised Register contains studies identified from several sources. </p> <p> <ol id="CD013119-list-0008"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Searches of kidney and transplant journals, and the proceedings and abstracts from major kidney and transplant conferences </p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney and transplant journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of search strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available on the <a href="https://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant website</a>. </p> <p>See <a href="./appendices#CD013119-sec-0124">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD013119-sec-0027"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD013119-list-0009"> <li> <p>Reference lists of review articles, relevant studies, and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD013119-sec-0028"> <h3 class="title" id="CD013119-sec-0028">Data collection and analysis</h3> <section id="CD013119-sec-0029"> <h4 class="title">Selection of studies</h4> <p>We used the search strategy described to obtain titles and abstracts of studies that may be relevant to the review. The titles and abstracts were screened independently by two authors. Studies that were not relevant were discarded. However studies and reviews thought to include relevant data or information on studies were retained initially. Two authors independently assessed retrieved abstracts, and when necessary the full text of these studies to determine which studies satisfied the inclusion criteria. Any differences were resolved by discussion and, when necessary, by consultation with a third author. </p> </section> <section id="CD013119-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>For the studies that fulfilled the inclusion criteria, data extraction was carried out by two independent authors using standard data extraction forms. Studies reported in non‐English language were translated before assessment. Where more than one publication from the same study was found, reports were grouped together and the publication with the most complete data was used in the analyses. Where relevant outcomes were only published in earlier versions, these data were used. Any discrepancy between published versions were highlighted and any disagreements that were not resolved through discussion between the two authors were resolved in consultation with a third author. </p> </section> <section id="CD013119-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by two authors using the risk of bias assessment tool (<a href="./references#CD013119-bbs2-0047" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) (see <a href="./appendices#CD013119-sec-0125">Appendix 2</a>). </p> <p> <ul id="CD013119-list-0010"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD013119-list-0011"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD013119-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (e.g. death, CVD), results were expressed as risk ratio (RR) with 95% confidence intervals (CI). Where continuous scales of measurement were used to assess the effects of treatment (anthropometric and biochemical markers), the mean difference (MD) was used, or the standardised mean difference (SMD) was used if different scales were used. </p> </section> <section id="CD013119-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <section id="CD013119-sec-0034"> <h5 class="title">Cluster‐randomised studies</h5> <p>There were no cluster‐randomised studies included in this meta‐analysis.</p> </section> <section id="CD013119-sec-0035"> <h5 class="title">Cross‐over studies</h5> <p>Cross‐over studies were analysed using only the data from the first period.</p> </section> <section id="CD013119-sec-0036"> <h5 class="title">Studies with more than two treatment arms</h5> <p>Studies with multiple intervention groups were included. When considering these studies we tried to combine all relevant experimental intervention groups of the study into a single group and combined all relevant control intervention groups into a single group to enable single pair wise comparison. </p> </section> </section> <section id="CD013119-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>Any further information required from the original authors was requested by written correspondence (emailing corresponding author) and any relevant information obtained in this manner was included in the review. Evaluation of important numerical data, such as number of patients screened, randomised patients as well as intention‐to‐treat, as‐treated and per‐protocol populations, was performed. Attrition rates, for example drop‐outs, losses to follow‐up and withdrawals were investigated. Issues of missing data and imputation methods (for example, last‐observation‐carried‐forward) were critically appraised (<a href="./references#CD013119-bbs2-0047" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD013119-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>We first assessed the heterogeneity by visual inspection of the forest plot. Heterogeneity was then analysed using the I² statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than sampling error (<a href="./references#CD013119-bbs2-0046" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [MEDLINE: 12958120]">Higgins 2003</a>). A guide to the interpretation of I² values was as follows. </p> <p> <ul id="CD013119-list-0012"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity</p> </li> </ul> </p> <p>The importance of the observed value of I² depends on the magnitude and direction of treatment effects and the strength of evidence for heterogeneity (e.g. P‐value from the Chi² test, or a confidence interval for I²) (<a href="./references#CD013119-bbs2-0047" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD013119-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>Due to the small number of studies we were unable to assess for the existence of small study bias using funnel plots. </p> </section> <section id="CD013119-sec-0040"> <h4 class="title">Data synthesis</h4> <p>We classified our studies by type of intervention lifestyle: including dietary, physical activity, behaviour change, pharmacological and surgical interventions. Data were summarised using the random‐effects model although the fixed‐effects model was also analysed to ensure robustness of the model chosen and susceptibility to outliers. When evidence of sizeable clinical, methodological, and statistical heterogeneity across included studies was evident across studies we were not able to pool results to from a meta‐analysis and instead a reported a narrative approach to this data synthesis. </p> </section> <section id="CD013119-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>To explore for possible sources of heterogeneity in our protocol we stated we would conduct the following subgroup analyses if adequate data were available. </p> <p> <ul id="CD013119-list-0013"> <li> <p>BMI (overweight versus obese)</p> </li> <li> <p>Stage of CKD and modality (HD, PD, transplantation, supportive care)</p> </li> <li> <p>Duration of intervention (≤ 3 months versus &gt; 3 months)</p> </li> <li> <p>Chief causes of CKD, (diabetes, hypertension, glomerulonephritis, polycystic kidney disease, reflux kidney disease) </p> </li> <li> <p>Presence or absence of proteinuria</p> </li> </ul> </p> </section> <section id="CD013119-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>Where sufficient studies were available, we investigated the following:</p> <p> <ul id="CD013119-list-0014"> <li> <p>Repeating the analysis excluding unpublished studies;</p> </li> <li> <p>Repeating the analysis taking account of risk of bias, as specified;</p> </li> <li> <p>Repeating the analysis excluding any very long or large studies to establish how much they dominate the results; and </p> </li> <li> <p>Repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), country. </p> </li> </ul> </p> </section> <section id="CD013119-sec-0043"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We presented the main results of the review in 'Summary of findings' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD013119-bbs2-0055" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Schunemann 2011a</a>). The 'Summary of findings' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD013119-bbs2-0043" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6. [MEDLINE: 18436948]">GRADE 2008</a>; <a href="./references#CD013119-bbs2-0044" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94. [MEDLINE: 21195583]">GRADE 2011</a>). The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD013119-bbs2-0056" title="SchünemannHJ , OxmanAD , HigginsJP , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Schunemann 2011b</a>). </p> <p>The key outcomes presented in the Summary of findings Table 1 include:</p> <p> <ol id="CD013119-list-0015"> <li> <p>Death (any cause)</p> </li> <li> <p>Cardiovascular events</p> </li> <li> <p>Weight loss/post intervention body weight</p> </li> <li> <p>BMI</p> </li> <li> <p>Waist circumference</p> </li> <li> <p>Proteinuria</p> </li> <li> <p>BP: SBP and DBP.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013119-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013119-sec-0044"></div> <section id="CD013119-sec-0045"> <h3 class="title">Description of studies</h3> <p>For a detailed description of studies, see <a href="./references#CD013119-sec-0136" title="">Characteristics of included studies</a>; <a href="./references#CD013119-sec-0137" title="">Characteristics of excluded studies</a> and <a href="./references#CD013119-sec-0138" title="">Characteristics of ongoing studies</a> sections. </p> <section id="CD013119-sec-0046"> <h4 class="title">Results of the search</h4> <p>The electronic search of the Cochrane Kidney and Transplant Specialised Register (up to 14 December 2020) identified 154 records. An additional 39 records were found when we searched the reference lists of included studies and relevant reviews, resulting in a total of 193 unique records. </p> <p>We screened the titles and abstracts of these 193 records and a further 84 records were excluded (not randomised, wrong population and/or interventions). We obtained and reviewed the remaining 109 full‐text records (33 studies). A further 55 records were excluded (not intentional weight intervention studies, ≤ 4 weeks duration). Two ongoing studies were identified (<a href="./references#CD013119-bbs2-0032" title="SevickMA , WoolfK , MattooA , KatzSD , LiH , St-JulesDE , et al. The Healthy Hearts and Kidneys (HHK) study: Design of a 2x2 RCT of technology-supported self-monitoring and social cognitive theory-based counseling to engage overweight people with diabetes and chronic kidney disease in multiple lifestyle changes. Contemporary Clinical Trials2018;64:265-73. [MEDLINE: 28867396]">HHK 2018</a>; <a href="./references#CD013119-bbs2-0033" title="SpaggiariM , Di CoccoP , TullaK , KaylanKB , MasrurMA , HassanC , et al. Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. American Journal of Transplantation 2020 Sep 25 [epub ahead of print]. [MEDLINE: 32976702]West-ThielkeP , TullaKA , OkoyeOT , Almario AlvarezJA , SpaggiariM , TzvetanovIG , et al. Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure [abstract]. American Journal of Transplantation2019;19:331-2. [EMBASE: 628454944]">Spaggiari 2020</a>); these studies will be assessed in a future update of this review. Thirty‐three records from 17 studies met the inclusion criteria (see <a href="#CD013119-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD013119-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013119-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013119-sec-0047"> <h4 class="title">Included studies</h4> <p>The <a href="./references#CD013119-sec-0136" title="">Characteristics of included studies</a> table provides details of the included studies. The following gives a brief overview. </p> <p>Included studies were published between 1975 and 2019. Data were obtained from both published literature, supplementary unpublished data, and trial registers. Additional data were requested for 11 studies via correspondence with study authors (see <a href="./appendices#CD013119-sec-0126">Appendix 3</a>). One study was translated from Czech to English (<a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>). </p> <section id="CD013119-sec-0048"> <h5 class="title">Study design</h5> <p>This review included 17 studies (51 reports; 988 randomised participants). Sixteen studies had a parallel design and one study (<a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) had a cross‐over design. The majority (11) were single centre studies (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) and were carried out in hospital outpatient clinics (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>). </p> </section> <section id="CD013119-sec-0049"> <h5 class="title">Location of studies</h5> <p>Five of the 17 included studies were conducted in the USA (<a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a>; <a href="./references#CD013119-bbs2-0017" title="WoolfK , GanguzzaL , PompeiiML , HuL , St-JulesDE , JagannathanR , et al. Weight loss and self-efficacy in obese/overweight patients with type 2 diabetes and chronic kidney disease in a lifestyle intervention pilot study [abstract]. FASEB journal2017;31(1 Suppl 1). [EMBASE: 616960059]">Woolf 2017</a>), three were in Australia (<a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>), two each in Spain (<a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>), the UK (<a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) and Czech Republic (<a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>; <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>), and one study each in Thailand (<a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>), Israel (<a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>) and Brazil (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>). </p> </section> <section id="CD013119-sec-0050"> <h5 class="title">Participants</h5> <p>The included studies involved a total of 988 overweight or obese participants with CKD. The number of participants in included studies ranged from 6 to 258. The mean age of participants was 42.5 ± 4.5 to 65.9 ± 9.7 years. Thirteen studies (620 participants) investigated the effects of weight loss in people with CKD stages 1 to 4 and four studies (368 participants) were conducted with transplant recipients (<a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>; <a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a>). None of the included studies involved participants undergoing dialysis (HD or PD) nor supportive care. </p> </section> <section id="CD013119-sec-0051"> <h5 class="title">Comparisons</h5> <p>We identified three comparisons for analysis, separated by intervention type.</p> <section id="CD013119-sec-0052"> <h6 class="title">1) Any weight loss intervention versus usual care or control (main comparison)</h6> <section id="CD013119-sec-0053"> <p><b>Lifestyle versus usual care</b></p> <p> <ul id="CD013119-list-0016"> <li> <p>Dietary versus usual care or control</p> <ul id="CD013119-list-0017"> <li> <p><a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a> evaluated a daily energy restriction of 2100 kJ versus usual dietary intake </p> </li> <li> <p><a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a> compared a daily energy restriction of 2100 kJ with a daily protein target of 0.6 to 0.8 g/kg/day versus no energy restriction and a daily protein target of 0.6 to 0.8g/kg/day </p> </li> <li> <p><a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a> evaluated a daily energy intake of 4200 to 5900 kJ/day versus usual diet habits plus captopril treatment. </p> </li> </ul> </li> <li> <p>Physical activity versus usual care or control</p> <ul id="CD013119-list-0018"> <li> <p><a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a> evaluated the effects of in‐centre and home‐based aerobic exercise performed 3 times/week for 12 weeks versus control </p> </li> <li> <p><a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a> compared the effects of 3 times/week aerobic exercise training for 6 weeks in centre followed by 18 weeks of supervised home exercise versus usual care. </p> </li> </ul> </li> <li> <p>Behavioural versus usual care or control</p> <ul id="CD013119-list-0019"> <li> <p><a href="./references#CD013119-bbs2-0017" title="WoolfK , GanguzzaL , PompeiiML , HuL , St-JulesDE , JagannathanR , et al. Weight loss and self-efficacy in obese/overweight patients with type 2 diabetes and chronic kidney disease in a lifestyle intervention pilot study [abstract]. FASEB journal2017;31(1 Suppl 1). [EMBASE: 616960059]">Woolf 2017</a> compared the differences in weight between an intensive Social Cognitive Theory–based lifestyle intervention to a standard behaviour treatment over 6 months. </p> </li> </ul> </li> <li> <p>Mixed lifestyle versus usual care or control</p> <ul id="CD013119-list-0020"> <li> <p>The effects of lifestyle intervention consisting of dietary modifications and increasing physical activity on metabolic outcomes compared to usual care was examined in CKD recipients in two studies (<a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>) and in transplant recipients in one study (<a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>). </p> </li> </ul> </li> </ul> </p> <p><i>Pharmacological versus usual care or control</i> </p> <p> <ul id="CD013119-list-0021"> <li> <p>Appetite suppressant versus dietary</p> <ul id="CD013119-list-0022"> <li> <p><a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a> (trial 2) evaluated the effects of fenfluramine compared to placebo over 6 weeks among transplant recipients. </p> </li> </ul> </li> </ul> </p> <p><i>Mixed intervention versus usual care or control</i> </p> <p> <ul id="CD013119-list-0023"> <li> <p>Lifestyle (dietary) plus pharmacological (appetite suppressant) versus usual care or control </p> <ul id="CD013119-list-0024"> <li> <p><a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a> assessed the effects of a hypo‐energetic and hypolipidaemic diet supplemented with orlistat compared to usual care over 3 years. </p> </li> </ul> </li> </ul> </p> </section> </section> <section id="CD013119-sec-0054"> <h6 class="title">2) Any weight loss intervention versus dietary intervention</h6> <p><i>Lifestyle (dietary) versus lifestyle (dietary)</i> </p> <p> <ul id="CD013119-list-0025"> <li> <p><a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a> explored the effects of 3 different diets; a low fat energy restricted diet (6300 kJ for women and 7500 kJ for men with a goal of 30% energy coming from fat); a Mediterranean energy restricted diet (6300 kJ for women and 7500 kJ for men, goal no more than 35% of energy from fat, main sources of fat were 30 to 45 g of olive oil and a handful of nuts per day) and a low carbohydrate non‐energy restricted diet (modified Atkins diet ‐ goal for 20 g of carbohydrates per day for the 2‐month induction phase gradual increase to a maximum of 120 g/day ‐ the intake of total energy, protein, and fat were not limited). </p> </li> <li> <p><a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> investigated the effects of a low protein (0.6 g/kg/day) and energy restricted diet (120 to 125 kJ/kg/day for the first 6 months then 125 to 130 kJ/kg/day thereafter for 3 years) supplemented twice with either keto acid supplementation or placebo. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> evaluated the effects of a moderate versus standard protein weight loss diet 6000 kJ/day for women, or 7000 kJ/day for men with either a protein intake goal of 90 to 120 g/day (moderate protein) or 55 to 70 g/day (standard protein). </p> </li> </ul> </p> <p><i>Lifestyle (dietary and exercise) versus lifestyle (dietary)</i> </p> <p> <ul id="CD013119-list-0026"> <li> <p><a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> examined the effects of an exercise and diet intervention (12 weeks of 3 times/week exercise training followed by 40 weeks of supervised home exercise plus daily 800 to 1000 kJ energy restriction) versus usual medical care. </p> </li> </ul> </p> <p><i>Lifestyle (dietary) versus lifestyle (dietary)</i> </p> <p> <ul id="CD013119-list-0027"> <li> <p><a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>, <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> and <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> examined the effects of various energy restricted diets on weight loss and kidney function. </p> </li> </ul> </p> <p><i>Pharmacological (appetite suppressant) versus dietary</i> </p> <p> <ul id="CD013119-list-0028"> <li> <p><a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a> (trial 1) evaluated the effects of fenfluramine compared to placebo over 6 weeks. </p> </li> </ul> </p> </section> <section id="CD013119-sec-0055"> <h6 class="title">3) Surgical intervention versus non‐surgical intervention</h6> <p><i>Surgical (sleeve gastrectomy) versus lifestyle (standard weight loss program)</i> </p> <p> <ul id="CD013119-list-0029"> <li> <p><a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a> explored the effectiveness of combined robotic kidney transplantation and sleeve gastrectomy versus robotic kidney transplantation and standard weight loss program. </p> </li> </ul> </p> <p><i>Surgical (sleeve gastrectomy) versus pharmacological (lipase inhibitor) and lifestyle (dietary)</i> </p> <p> <ul id="CD013119-list-0030"> <li> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> explored the effect of sleeve gastrectomy compared to best medical care (individualised dietary and physical activity prescription plus orlistat). </p> </li> </ul> </p> <p>A summary of included studies and the types of weight loss interventions and the main comparators used can be found in <a href="./appendices#CD013119-sec-0127">Appendix 4</a>. Most (13 studies) explored the effects of lifestyle weight loss. Of these, eight compared lifestyle interventions against usual care or control (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>; <a href="./references#CD013119-bbs2-0017" title="WoolfK , GanguzzaL , PompeiiML , HuL , St-JulesDE , JagannathanR , et al. Weight loss and self-efficacy in obese/overweight patients with type 2 diabetes and chronic kidney disease in a lifestyle intervention pilot study [abstract]. FASEB journal2017;31(1 Suppl 1). [EMBASE: 616960059]">Woolf 2017</a>), four compared lifestyle interventions to other lifestyle interventions (<a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>) and one study (<a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>) compared the effects of three different lifestyle interventions to usual activity and diet. Two studies explored the efficacy of pharmacological interventions (<a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) and two studies compared mixed interventions not involving bariatric surgery to bariatric surgery (<a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a>). </p> </section> </section> </section> <section id="CD013119-sec-0056"> <h4 class="title">Excluded studies</h4> <p>During the full text screening a total of 55 records (14 studies) were excluded. The main reasons for exclusion were not a weight loss intervention or study duration &lt; 4 weeks. See <a href="./references#CD013119-sec-0137" title="">Characteristics of excluded studies</a> table for reasons for excluding each study. </p> </section> </section> <section id="CD013119-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>For details on risk of bias of included studies, see <a href="./references#CD013119-sec-0136" title="">Characteristics of included studies</a>. Methodological quality was quite varied, with many studies providing insufficient information to accurately judge the risk of bias. A summary of authors' judgements of the risk of bias for all included studies are shown in <a href="#CD013119-fig-0002">Figure 2</a>; and risk of bias in each individual study is shown in <a href="#CD013119-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD013119-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013119-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013119-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013119-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013119-sec-0058"> <h4 class="title">Allocation</h4> <section id="CD013119-sec-0059"> <h5 class="title">Random sequence generation</h5> <p>Random sequence generation was judged as low risk of bias in nine studies (<a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>) and unclear in the remaining eight studies. </p> </section> <section id="CD013119-sec-0060"> <h5 class="title">Allocation concealment</h5> <p>Four studies (<a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) described allocation concealment methods and all were assessed as low risk of bias. In the remaining 13 studies the risk of bias was unclear as the method of concealment was not adequately described to permit judgement. </p> </section> </section> <section id="CD013119-sec-0061"> <h4 class="title">Blinding</h4> <section id="CD013119-sec-0062"> <h5 class="title">Performance bias: participants</h5> <p>We judged two studies (<a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) to have a low risk of performance bias as participants were blinded to treatment allocation. We judged 11 studies as being at high risk of performance bias (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>) and four studies as having unclear risk of performance bias (<a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>; <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>; <a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a>; <a href="./references#CD013119-bbs2-0017" title="WoolfK , GanguzzaL , PompeiiML , HuL , St-JulesDE , JagannathanR , et al. Weight loss and self-efficacy in obese/overweight patients with type 2 diabetes and chronic kidney disease in a lifestyle intervention pilot study [abstract]. FASEB journal2017;31(1 Suppl 1). [EMBASE: 616960059]">Woolf 2017</a>). </p> </section> <section id="CD013119-sec-0063"> <h5 class="title">Performance bias: personnel</h5> <p>The risk of performance bias was assessed as being low in three studies (<a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) high in five studies (<a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>) and unclear in nine studies (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>; <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>; <a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a>; <a href="./references#CD013119-bbs2-0017" title="WoolfK , GanguzzaL , PompeiiML , HuL , St-JulesDE , JagannathanR , et al. Weight loss and self-efficacy in obese/overweight patients with type 2 diabetes and chronic kidney disease in a lifestyle intervention pilot study [abstract]. FASEB journal2017;31(1 Suppl 1). [EMBASE: 616960059]">Woolf 2017</a>). </p> </section> <section id="CD013119-sec-0064"> <h5 class="title">Detection bias</h5> <p>We assessed the risk of detection bias for objective outcomes as low for all studies regardless of whether or not outcome assessors were blinded. </p> <p>In the seven studies that included subjective outcomes measures we judged detection bias to be low in two studies (<a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>), high in one study (<a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>) as they did not undertake blinding of outcome assessors, and unclear in four studies (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>) because blinding was not adequately reported. </p> </section> </section> <section id="CD013119-sec-0065"> <h4 class="title">Incomplete outcome data</h4> <p>Only five studies (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>) were considered to be at low risk of attrition bias. Three studies (<a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) were assessed to be at high risk of bias as more than 20% of participants were lost to follow‐up. Attrition bias in the remaining nine studies was judged unclear due to insufficient information. </p> </section> <section id="CD013119-sec-0066"> <h4 class="title">Selective reporting</h4> <p>We judged studies to be at high risk of reporting bias if planned outcomes were not adequately reported. Four studies (<a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>; <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>) were judged to be at low risk of selective reporting bias. Three studies (<a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>) were judged to be at high risk of selective reporting bias, and 10 studies were judged unclear risk due to insufficient information available to permit judgement. </p> </section> <section id="CD013119-sec-0067"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies were assessed as high risk of other bias: <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> used blocked randomisation in an unblinded RCT and the study had a very low recruitment uptake of 10%, and <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a> used post hoc reporting of sub‐groups with CKD stages 3 to 4. Five studies (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>) appeared to be free of other sources of bias and were judged low risk. The remaining 10 studies were assessed to have unclear risk of bias due to insufficient information to permit judgement. </p> </section> </section> <section id="CD013119-sec-0068"> <h3 class="title" id="CD013119-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD013119-tbl-0001"><b>Summary of findings 1</b> Any weight loss intervention compared to usual care or control</a> </p> <p>See <a href="./full#CD013119-tbl-0001">summary of findings Table 1</a> for the main comparison weight loss interventions (lifestyle, pharmacological, bariatric surgery) compared to usual care or placebo in CKD populations. </p> <p>The studies were analysed using both random effects and fixed effects models and found no difference between the two models. The results below therefore refer to those obtained using a random‐effects model. </p> <section id="CD013119-sec-0069"> <h4 class="title">Primary outcomes</h4> <section id="CD013119-sec-0070"> <h5 class="title">Death (any cause) and cardiovascular events</h5> <p>None of the included studies evaluated the effects of weight loss on death or cardiovascular events. </p> </section> <section id="CD013119-sec-0071"> <h5 class="title">Weight loss</h5> <p>Weight loss interventions compared to usual care or control may lead to weight loss and reduced post intervention body weight (<a href="./references#CD013119-fig-0004" title="">Analysis 1.1</a> (6 studies, 180 participants): MD ‐3.69 kg, 95% CI ‐5.82 to ‐1.57; I² = 59%). The certainty of the evidence was very low due to high or uncertain risk of bias, moderate heterogeneity, imprecision, and indirectness. Three additional studies (<a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a>; <a href="./references#CD013119-bbs2-0017" title="WoolfK , GanguzzaL , PompeiiML , HuL , St-JulesDE , JagannathanR , et al. Weight loss and self-efficacy in obese/overweight patients with type 2 diabetes and chronic kidney disease in a lifestyle intervention pilot study [abstract]. FASEB journal2017;31(1 Suppl 1). [EMBASE: 616960059]">Woolf 2017</a>) had data which could not be statistically pooled, however were consistent with the meta‐analysis, with all three reporting significant improvements in body weight in the weight loss intervention groups compared to their respective control. </p> <p>There was little or no difference between any weight loss intervention compared to dietary interventions for weight loss (<a href="./references#CD013119-fig-0021" title="">Analysis 2.1</a> (3 studies, 155 participants): MD 0.76 kg, 95% CI ‐2.125 to 3.66; I² = 0%). <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a> could not be pooled however reported similar findings to the meta‐analysis. <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>, which had three different dietary arms, remained robust to the primary finding when each intervention comparison was rotated through <a href="./references#CD013119-fig-0021" title="">Analysis 2.1</a>. </p> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported surgical intervention participants (sleeve gastrectomy) lost 29.50 kg (95% CI 23.35 to 35.65 kg) more weight compared to control participants who received a combined diet and pharmacological treatment. </p> <section id="CD013119-sec-0072"> <h6 class="title">Stage of chronic kidney disease</h6> <p>There was no little or no difference in total weight loss following any weight loss intervention compared to usual care or control in CKD stages 1 to 4 (<a href="./references#CD013119-fig-0050" title="">Analysis 4.1</a>.1) or in transplant recipients (<a href="./references#CD013119-fig-0050" title="">Analysis 4.1</a>.2). </p> </section> <section id="CD013119-sec-0073"> <h6 class="title">Intervention duration</h6> <p>There was little or no difference in total weight loss for any weight loss intervention given for 3 months or less (<a href="./references#CD013119-fig-0052" title="">Analysis 5.1</a>.1) or interventions given for more than 3 months (<a href="./references#CD013119-fig-0052" title="">Analysis 5.1</a>.2). The test for subgroup differences showed no difference between the two time frames (test for subgroup differences: Chi² = 0.02, df = 1 (P = 0.88), I² = 0%). </p> </section> </section> <section id="CD013119-sec-0074"> <h5 class="title">Body mass index</h5> <p>Weight loss interventions had uncertain effects on BMI (<a href="./references#CD013119-fig-0005" title="">Analysis 1.2</a> (4 studies, 100 participants): MD ‐2.18 kg/m², 95% CI ‐4.90 to 0.54; I²= 60%). The certainty of the evidence was very low due to high or uncertain risk of bias, moderate heterogeneity, imprecision, and indirectness. Five studies were unable to be meta‐analysed; all found any weight loss interventions led to significantly lower BMI when compared to usual care or control (<a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a>; <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>; <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>; <a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a>). </p> <p>In studies involving any weight loss intervention compared to dietary intervention there was little or no difference to post‐intervention BMI (<a href="./references#CD013119-fig-0022" title="">Analysis 2.2</a> (3 studies, 262 participants): MD ‐1.27 kg/m², 95% CI ‐4.43 to 1.89; I² = 87%). </p> <p>In studies involving surgical interventions BMI was probably reduced in sleeve gastrectomy when compared to non‐surgical interventions (<a href="./references#CD013119-fig-0042" title="">Analysis 3.2</a> (2 studies, 17 participants): MD ‐10.43 kg/m², 95% CI ‐13.58 to ‐7.29: I² = 42%). </p> <section id="CD013119-sec-0075"> <h6 class="title">Intervention duration</h6> <p>Weight loss interventions given for more than 3 months probably reduced BMI (<a href="./references#CD013119-fig-0053" title="">Analysis 5.2</a>.3 (3 studies, 73 participants): MD ‐3.36 kg/m², 95% CI ‐5.68 to ‐1.04; I² = 9%), whereas interventions given for 3 months or less possibly made little of no difference to BMI (<a href="./references#CD013119-fig-0053" title="">Analysis 5.2</a>.1). </p> </section> </section> <section id="CD013119-sec-0076"> <h5 class="title">Waist circumference</h5> <p>Two studies using dietary intervention (<a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>) and exercise (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>) showed little or no difference to waist circumference when compared to usual care (<a href="./references#CD013119-fig-0006" title="">Analysis 1.3</a> (2 studies, 53 participants) MD ‐0.68 cm, 95% CI ‐7.6 to 6.24; I² = 40%). The certainty of evidence was very low due to high or uncertain risk of bias, moderate heterogeneity, imprecision, and indirectness. Two studies (<a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a>; <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a>) could not be pooled into the meta‐analysis. <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> also found no difference between the two groups, while <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a> reported significant reductions in waist circumference following a combined diet and exercise intervention compared to usual care. </p> <p><a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a> compared weight loss interventions to dietary interventions and reported no effect on waist circumference across three different dietary interventions (low‐fat, low‐carbohydrate, and Mediterranean diet) in CKD participants. </p> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> compared surgical to non‐surgical interventions and reported waist circumference was reduced following sleeve gastrectomy surgery compared to a combined pharmacological and diet intervention in CKD participants (<a href="./references#CD013119-fig-0041" title="">Analysis 3.1</a> (1 study, 11 participants): MD ‐30.00 cm, 95% CI ‐39.93 to ‐20.07). </p> </section> <section id="CD013119-sec-0077"> <h5 class="title">Waist‐to‐hip ratio</h5> <p>Two studies comparing weight loss intervention to usual care or control had uncertain effects on waist‐to‐hip ratio. <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> reported no difference in waist‐to‐hip ratio between the two groups following a 6‐month dietary and exercise intervention (MD ‐1.05, 95% CI ‐5.92 to 3.82). <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a> reported a reduction in waist‐to‐hip ratio in the dietary energy restricted group compared to the usual diet group (P = 0.03), but not in the exercise‐only intervention (P = 0.72). </p> <p>In studies comparing any weight loss intervention to diet intervention, <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> reported waist‐to‐hip ratio reduced by ‐0.05 units (95% CI ‐0.07 to ‐0.03) in participants following an energy restricted diet with concurrent keto‐amino acid supplementation compared to those following a low protein and energy restricted diet with placebo supplementation. </p> </section> <section id="CD013119-sec-0078"> <h5 class="title">Body composition measures (fat mass, lean body mass and muscle mass)</h5> <p>Four studies comparing weight loss intervention to usual care or control, had uncertain effects on fat mass and lean body mass. </p> <p> <ul id="CD013119-list-0031"> <li> <p><a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a> reported a reduced body fat (24.8% compared to 26.2%, measured by bioelectrical impedance analysis (BIA)) and no change in muscle mass, in a diet‐only intervention compared to usual care. In contrast, <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a> found no effect on body fat or lean body mass (measured by air displacement plethysmography) following 24 weeks of aerobic exercise. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a> had mixed results, finding an exercise‐only intervention to have no effect on total body fat (measured by dual‐energy X‐ray absorptiometry (DEXA) scan) following either in‐centre exercise or home‐based exercise. However, exercise intervention groups had reductions in visceral fat when compared to control. After 12 weeks of aerobic exercise the in‐centre exercise group saw improvements in total lean body mass (kg) due to an increase in leg lean mass however these benefits were not achieved in the home exercise group nor control group. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a> reported a reduction in body fat (measured by DEXA) with a combined diet and exercise intervention compared to usual care (MD ‐0.5%, 95% CI ‐1.9 to 0.8) as well as in the diet‐alone intervention reduced body fat compared to usual care (MD ‐1.6%, 95% CI ‐2.9 to ‐0.3). However the exercise‐alone intervention compared to usual care did not show a reduction in body fat. </p> </li> </ul> </p> <p>Comparing any weight loss intervention to dietary interventions had uncertain effects on body composition. </p> <p> <ul id="CD013119-list-0032"> <li> <p><a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> compared energy restricted diets with different levels of protein and reported weight loss resulted in a fat mass loss (measured by DEXA scan in 42 participants) of 6.2 ± 7.7 kg in the moderate protein group and 4.9 ± 5.1 kg in the standard protein group. Similar lean fat mass changes were also reported amongst groups: 1.7 ± 2.7 kg in the moderate protein group and 1.8 ± 2.9 kg in the standard protein group. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> reported no change in fat mass (kg), percentage body fat, or lean weight (kg) (measured by air displacement plethysmography) in either the exercise and diet group or diet alone group. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> reported a greater reduction in visceral fat (measured by magnetic resonance spectroscopy) in those following an energy restricted lower protein diet supplemented with keto‐amino acid supplementation then those following an energy restricted lower protein diet with placebo supplementation. </p> </li> </ul> </p> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported surgical intervention participants lost 24.1 kg (95% CI 32.5 to 15.7) more fat mass (measured by BIA) compared to best medical care control participants who received combined lifestyle and pharmacological treatment. </p> </section> </section> <section id="CD013119-sec-0079"> <h4 class="title">Secondary outcomes</h4> <section id="CD013119-sec-0080"> <h5 class="title">Creatinine clearance</h5> <p>Weight loss interventions had uncertain effects on CrCl when compared to usual care or control (<a href="./references#CD013119-fig-0008" title="">Analysis 1.5</a> (3 studies, 58 participants): SMD 0.29, 95% CI ‐0.34 to 0.91: I² = 20%). <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a>, reported a significant reduction in CrCl in transplant recipients following a combined diet and pharmacological intervention (from 1.2 mL/s at baseline to 0.9 mL/s at 3‐year follow‐up), however no comparison data for the usual care arm was reported. </p> <p><a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> reported a significant reduction post intervention in CrCl in the weight loss intervention (low protein and energy restricted diet with concurrent keto‐amino acid supplementation) of 33.5 mL/min/1.73 m² compared to 25.8 mL/min/1.73 m² in the low protein and energy restricted diet group with placebo supplementation. </p> </section> <section id="CD013119-sec-0081"> <h5 class="title">Serum creatinine</h5> <p>Weight loss interventions compared to usual care or control had uncertain effects on SCr (<a href="./references#CD013119-fig-0009" title="">Analysis 1.6</a> (4 studies, 84 CKD participants): MD ‐0.15 mg/dL, 95% CI ‐0.52 to 0.22); I² = 23%). The quality of evidence was considered to be low due to high or uncertain risk of bias, and imprecision (small sample size). </p> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported no statistically significant change in SCr in CKD participants following a surgical (sleeve gastrectomy) intervention compared to a combined pharmacological and diet therapy. </p> </section> <section id="CD013119-sec-0082"> <h5 class="title">Proteinuria</h5> <p>Weight loss interventions compared to usual care or control had uncertain effects on proteinuria (<a href="./references#CD013119-fig-0010" title="">Analysis 1.7</a> (4 studies, 84 participants): MD ‐0.29 g/day, 95% CI ‐0.76 to 0.18: I² = 33%). The certainty of evidence was very low due to high or uncertain risk of bias, imprecision, and indirectness. <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a> reported a reduction in proteinuria in transplant recipients following a combined diet and pharmacological intervention, however no data for the control arm was reported. </p> <p><a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> reported a combined diet and exercise intervention in CKD participants reduced proteinuria compared to a diet‐only intervention (405 mg/g compared to 618 mg/g), respectively. </p> </section> <section id="CD013119-sec-0083"> <h5 class="title">Albuminuria</h5> <p>Three studies conducted in CKD participants reported on albuminuria and all reported no effect following an exercise intervention compared to usual care (<a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>), standard protein energy restricted diet compared to a moderate protein energy restricted diet (<a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>), and diet and exercise intervention versus diet alone (<a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a>). </p> </section> <section id="CD013119-sec-0084"> <h5 class="title">Measured GFR</h5> <p>Weight loss interventions versus dietary intervention and had uncertain effects on measured GFR. <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> reported a change in measured GFR with an energy restricted diet supplemented with keto‐amino acids compared to an energy restricted low protein diet, and <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> reported a change in measured GFR with a moderate protein energy restricted diet compared to a standard protein energy restricted diet (<a href="./references#CD013119-fig-0027" title="">Analysis 2.7</a> (2 studies, 176 CKD participants): SMD 0.63, 95% CI 0.25 to 1.02: I² = 29%). </p> </section> <section id="CD013119-sec-0085"> <h5 class="title">Glomerular hyperfiltration</h5> <p><a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> reported weight loss in both the energy restricted moderate protein and standard protein diets resulted in a decline in eGFR of 15 mL/min in participants with hyperfiltration (defined by a GFR &gt; 120 mL/min). </p> </section> <section id="CD013119-sec-0086"> <h5 class="title">Blood pressure</h5> <p>Weight loss interventions had an uncertain effect on SBP (<a href="./references#CD013119-fig-0011" title="">Analysis 1.8</a> (4 studies, 139 CKD participants): MD ‐5.90 mmHg, 95% CI –13.75 to 1.96: I² = 64%) and DBP (<a href="./references#CD013119-fig-0012" title="">Analysis 1.9</a> (4 studies, 139 CKD participants): MD ‐5.49 mmHg, 95% CI –11.13 to 0.14: I² = 63%) when compared to usual care or control. The certainty of evidence was very low due to high or uncertain risk of bias, imprecision, and indirectness. <a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a> reported median data which could not be pooled, however commensurate with our meta‐analysis, they found no significant reduction in SBP or DBP following a combined diet and exercise intervention, or in diet‐ or exercise‐alone interventions, compared to usual care. </p> <p>Any weight loss interventions made little or no difference to SBP compared to dietary interventions (<a href="./references#CD013119-fig-0028" title="">Analysis 2.8</a> (3 studies, 262 CKD participants): MD ‐2.33 mmHg, 95% CI ‐8.32 to 3.67: I² = 71%), which remained robust with substitution as each of the three dietary arms were rotated through the meta‐analysis from <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>. <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> similarly reported no change in SBP following a standard protein energy restricted diet compared to a moderate protein energy restricted diet, however, did not report the outcome data to allow for data pooling. </p> <p>In contrast, DBP was probably reduced with any weight loss intervention when compared to diet‐alone comparators (<a href="./references#CD013119-fig-0029" title="">Analysis 2.9</a> (3 studies, 246 CKD participants): MD ‐1.87 mmHg, 95% CI ‐3.59 to ‐0.14: I² = 0%). </p> </section> <section id="CD013119-sec-0087"> <h5 class="title">Anti‐hypertensive medication changes</h5> <p><a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a> reported that the numbers, classes, and doses of antihypertensive drugs administered to both the dietary intervention group and control group were similar. </p> </section> <section id="CD013119-sec-0088"> <h5 class="title">Glycosylated haemoglobin</h5> <p>Weight loss interventions had uncertain effect on HbA1c versus usual care or control (<a href="./references#CD013119-fig-0013" title="">Analysis 1.10</a> (2 studies, 83 CKD participants): MD ‐0.48%, 95% CI ‐1.15 to 0.18: I2 = 0%). </p> <p>Weight loss interventions made little or no difference to HbA1c when compared to diet comparators (<a href="./references#CD013119-fig-0030" title="">Analysis 2.10</a> (2 studies, 163 CKD participants): MD ‐1.62%, 95% CI ‐3.87 to 0.63: I² = 89%). <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> reported HbA1c reduced by 0.3% (equivalent to 2 mmol/mol) across both diet study groups, with no difference observed between the two diet groups. </p> </section> <section id="CD013119-sec-0089"> <h5 class="title">Fasting blood glucose</h5> <p>Weight loss interventions had an uncertain effects on fasting blood glucose levels compared to usual care or control (<a href="./references#CD013119-fig-0014" title="">Analysis 1.11</a> (2 studies, 98 CKD participants): MD ‐1.27 mg/dL, 95% CI ‐2.66 to 0.11: I² = 0%). <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a> reported a combined diet and pharmacological intervention years in transplant recipients significantly reduced fasting blood glucose from 7.6 mmol/L to 5.2 mmol/L at three years, however comparison data was not reported to allow for data pooling. </p> <p>Data from <a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> and <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a> comparing weight loss interventions to dietary intervention could not be pooled however, both found no difference in fasting blood glucose between the two groups. </p> </section> <section id="CD013119-sec-0090"> <h5 class="title">Hypoglycaemic medication changes</h5> <p>Three studies reported on hypoglycaemic medication changes with uncertain effects.</p> <p> <ul id="CD013119-list-0033"> <li> <p><a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> reported no difference between any weight loss intervention compared to usual care or control with regard to the use of metformin and insulin after a 2‐year follow‐up however, more participants in the lifestyle intervention group compared with control group were on a thiazolidinedione (25% versus 0%). </p> </li> <li> <p><a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> reported a variety of changes in hypoglycaemic medication use between two dietary study arms. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported daily mean insulin dose differed by ‐36 units (95% CI ‐69 to 23) in the surgical versus non‐surgical group who received individualised diet and exercise program with concurrent prescription of orlistat. </p> </li> </ul> </p> </section> <section id="CD013119-sec-0091"> <h5 class="title">Total cholesterol</h5> <p>Weight loss interventions made little or no difference to total cholesterol compared with usual care (<a href="./references#CD013119-fig-0015" title="">Analysis 1.12</a> (6 studies, 169 participants): MD ‐9.07 mg/dL, 95% CI ‐20.31 to 2.18: I² = 0%). <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a> reported a significant reduction in total cholesterol at 3 years in transplant recipients from 6.9 mmol/L to 5.2 mmol/L, however comparison data was not reported to allow for data pooling. </p> <p>Any weight loss intervention made little or no difference to total cholesterol compared with dietary interventions (<a href="./references#CD013119-fig-0033" title="">Analysis 2.13</a> (4 studies, 272 participants): MD ‐2.01 mg/dL, 95% CI ‐21.38 to 17.35: I² = 73%). This finding was robust despite which of the 3 different dietary arms were rotated through the meta‐analysis from <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>. </p> <section id="CD013119-sec-0092"> <h6 class="title">Stage of chronic kidney disease</h6> <p>There was little of no difference in total cholesterol following any weight loss intervention compared to usual care in either participants with CKD stages 1 to 4 or in transplant recipients (<a href="./references#CD013119-fig-0051" title="">Analysis 4.2</a>). </p> </section> <section id="CD013119-sec-0093"> <h6 class="title">Intervention duration</h6> <p>Weight loss interventions given for either less than 3 months or 3 months or more made little or no difference to total cholesterol (<a href="./references#CD013119-fig-0054" title="">Analysis 5.3</a>). </p> </section> </section> <section id="CD013119-sec-0094"> <h5 class="title">Low density lipoprotein cholesterol</h5> <p>Weight loss intervention probably leads to a reduction in LDL cholesterol compared with usual care or control (<a href="./references#CD013119-fig-0016" title="">Analysis 1.13</a> (4 studies, 139 participants): MD ‐10.30 mg/dL, 95% CI ‐16.70 to ‐3.90: I² = 0%). <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a> reported a reduction in total cholesterol at 3 years in transplant recipients from 4.1 mmol/L to 3.0 mmol/L, however comparison data was not reported to allow data pooling. </p> <p>Any weight loss intervention made little or no difference to LDL cholesterol compared with dietary interventions (<a href="./references#CD013119-fig-0034" title="">Analysis 2.14</a> (4 studies, 272 participants): MD 1.39 mg/dL, 95% CI ‐16.66 to 19.45: I² = 72%). This finding was robust despite which of the 3 different dietary arms were rotated through the meta‐analysis from <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a>. </p> </section> <section id="CD013119-sec-0095"> <h5 class="title">High density lipoprotein cholesterol</h5> <p>There was no effect little or no difference in HDL cholesterol with any weight loss intervention compared to usual care or control (<a href="./references#CD013119-fig-0017" title="">Analysis 1.14</a> (4 studies, 139 participants): MD 2.20 mg/dL, 95% CI ‐2.64 to 7.04: I² = 41%). </p> <p>Any weight loss intervention may reduce HDL cholesterol compared with dietary interventions (<a href="./references#CD013119-fig-0035" title="">Analysis 2.15</a> (2 studies, 131 participants): MD ‐4.80 mg/dL, 95% CI ‐8.71 to ‐0.89; I² = 0%). </p> </section> <section id="CD013119-sec-0096"> <h5 class="title">Triglycerides</h5> <p>Any weight loss intervention compared to usual care or control had uncertain effects on serum triglycerides (<a href="./references#CD013119-fig-0018" title="">Analysis 1.15</a> (5 studies, 156 CKD participants): MD ‐24.61 mg/dL, 95% CI ‐49.53 to 0.31: I² = 43%). Two other studies in transplant recipients reported mixed results however, they did not report appropriate data for pooling. <a href="./references#CD013119-bbs2-0013" title="TeplanV , SchuckO , PoledneR , VitkoS . Effective treatment of obesity reduces the risk after renal transplantation [abstract no: O134]. Nephrology Dialysis Transplantation2002;17(Suppl 1):40. [CENTRAL: CN-00509504] ">Teplan 2002</a> reported a reduction in triglycerides at 3 years from 3.8 mmol/L to 2.3 mmol/L. In contrast, <a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a> did not report any change in triglycerides following a pharmacological intervention compared to placebo. </p> <p>In studies comparing any weight loss intervention to dietary interventions, any weight loss intervention made little or no difference to triglycerides (<a href="./references#CD013119-fig-0036" title="">Analysis 2.16</a> (4 studies, 272 participants): MD ‐3.22 mg/dL, 95% CI ‐31.50 to 25.06: I² = 47%). <a href="./references#CD013119-bbs2-0002" title="ShaiI . The effect of low-carb, Mediterranean and low-fat diets on renal function: a 2-year dietary intervention randomized controlled trial (DIRECT) [abstract]. Obesity Facts2012;5(Suppl 1):19. [CENTRAL: CN-00868666] [EMBASE: 70781690]TiroshA , GolanR , Harman-BoehmI , HenkinY , SchwarzfuchsD , RudichA , et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care2013;36(8):2225-32. [MEDLINE: 23690533]">DIRECT 2013</a> reported no difference in triglycerides when comparing the effects of low‐carbohydrate, low‐fat and the Mediterranean diet. <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> also reported no difference in triglycerides when comparing a combined energy‐restricted and exercise intervention to an energy‐restricted diet alone (<a href="./references#CD013119-fig-0036" title="">Analysis 2.16</a>). <a href="./references#CD013119-bbs2-0014" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial. Aktuality v Nefrologii2008;14(4):185-90. [CENTRAL: CN-00791071] TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , C Keto Group. Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a> did however report the potential efficacy of one particular diet compared to another, showing a low protein and energy restricted diet with concurrent keto‐amino acid supplementation reduced serum triglycerides compared to low protein and energy restricted diet alone in CKD participants (<a href="./references#CD013119-fig-0036" title="">Analysis 2.16</a>). </p> </section> <section id="CD013119-sec-0097"> <h5 class="title">Lipid lowering medication changes</h5> <p><a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> reported that after a 2‐year follow‐up, more patients in the lifestyle intervention group were on a statin than those in the control group, 96% versus 80% respectively. </p> </section> <section id="CD013119-sec-0098"> <h5 class="title">Successful kidney transplantation</h5> <p>None of the included studies reported successful kidney transplantation.</p> </section> <section id="CD013119-sec-0099"> <h5 class="title">Inflammation (C‐reactive protein)</h5> <p><a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a> and <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a> both reported no effect of any weight loss intervention on C‐reactive protein compared to usual care. </p> <p><a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> found no effect of combined diet and exercise weight loss intervention on C‐reactive protein compared to a diet‐only intervention. </p> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported no effect of a surgical intervention (sleeve gastrectomy) on C‐reactive protein compared to best medical care (individualised dietary and physical activity prescription combined with orlistat prescription) in obese patients with CKD stages 3 to 4. </p> </section> <section id="CD013119-sec-0100"> <h5 class="title">Adherence to treatment</h5> <p><a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> reported the moderate protein group increased their protein intake to 1.22 g/kg/day and the standard protein group decreased their protein intake to 0.93 g/kg/day. </p> <p><a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a> reported all participants except one were within 20% of their assigned daily energy intake, and 70% of participants achieved an energy restriction lower than their assigned daily target. </p> <p><a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a> reported an adherence of 70% to supervised gym training sessions in the intervention group. <a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> reported an attendance of 42% and 34% for lifestyle modification classes in the dietary group and exercise + diet group, respectively. </p> <p>In surgical interventions versus non‐surgical interventions <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported a similar level of adherence with the best medical care group reporting four of the six patients (67%) attended over 90% of lifestyle program visits and all four were compliant, one was partially compliant and one non‐compliant with both the dietary and exercise interventions up to six months. <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported adherence with the initial liquid diet post‐surgery was 80% and 100% of patients continued to eat in accordance with the prescribed texture modification for three months and prescribed energy restriction up to 12 months. </p> </section> <section id="CD013119-sec-0101"> <h5 class="title">Health‐related quality of life</h5> <p><a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> did not find a combined diet and exercise weight loss intervention to improve overall QoL (as measured by The Short Form (36) Health Survey (SF‐36) compared to CKD participants receiving a diet‐only intervention. </p> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> found significant improvements in the physical domain of the SF‐36 questionnaire in CKD participants who received a sleeve gastrectomy compared to patients receiving an individualised diet and exercise program with concurrent prescription of orlistat. </p> </section> <section id="CD013119-sec-0102"> <h5 class="title">Nutritional status</h5> <p>None of the included studies reported the nutritional status of participants.</p> </section> <section id="CD013119-sec-0103"> <h5 class="title">Dietary intake</h5> <p>Compared to usual care or control, weight loss interventions made little or no difference to changes in dietary energy intake (<a href="./references#CD013119-fig-0020" title="">Analysis 1.17</a> (4 studies, 100 CKD participants): SMD ‐0.55, 95% CI ‐1.35 to 0.25: I² = 70%). </p> <p> <ul id="CD013119-list-0034"> <li> <p>Two of these studies (<a href="./references#CD013119-bbs2-0001" title="AoikeDT , BariaF , KamimuraMA , AmmiratiA , CuppariL . Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clinical &amp; Experimental Nephrology2018;22(1):87-98. [MEDLINE: 28643119]AoikeDT , BariaF , KamimuraMA , AmmiratiA , deMelloMT , CuppariL . Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease. International Urology &amp; Nephrology2015;47(2):359-67. [MEDLINE: 25503447]AoikeDT , BariaF , RochaML , KamimuraMA . Home-based vs in center aerobic exercise: Impact on cardiorespiratory (CR) and functional capacities (FC) of nondialysis dependent overweight CKD patients [abstract]. Kidney Research &amp; Clinical Practice2012;31(2):A27. [EMBASE: 70814753]BariaF , KamimuraMA , AoikeDT , AmmiratiA , LeisterRM , deMelloMT , et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrology Dialysis Transplantation2014;29(4):857-64. [MEDLINE: 24449105]GomesTS , AoikeDT , BariaF , GraciolliFG , MoysesRMA , CuppariL . Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. Journal of Renal Nutrition2017;27(5):364-71. [MEDLINE: 28606422]">Baria 2014</a>; <a href="./references#CD013119-bbs2-0007" title="BastJ , QureshiS , MoinuddinI , CollinsE , JelinekC , CooperC , et al. A randomized controlled trial of aerobic exercise in obese diabetic patients with chronic kidney disease [abstract no: PUB652]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):960A. [CENTRAL: CN-00740547] LeeheyD , MoinuddinI , BastJ , QureshiS , JelinekC , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology2009;8:62. [MEDLINE: 20003224]LeeheyDJ , MoinuddinI , BastJP , QureshiS , JelinekCS , CooperC , et al. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized, controlled feasibility study [abstract no: F-PO1328]. Journal of the American Society of Nephrology2009;20(Abstract Suppl):417A. ">Leehey 2009</a>) were exercise‐only interventions with no changes to dietary energy intake prescribed. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a> involved a combined dietary and exercise intervention found no difference in energy intake between groups post intervention </p> </li> <li> <p><a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a> study which involved an energy restricted dietary only intervention reported a significant reduction in energy intake post intervention in the intervention group compared to the control group. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> reported median end‐of study values in transplant recipients which could not be pooled, reported a combined diet and exercise intervention to reduced overall daily energy intake by 1293 kJ compared to usual care. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a> reported a non‐significant difference in overall energy intake following a standard protein energy restricted diet compared to a moderate protein energy restricted diet, with overall energy intakes of 6200 kJ and 6500 kJ at the end of the 12 month study, respectively. </p> </li> </ul> </p> <section id="CD013119-sec-0104"> <h6 class="title">Intervention duration</h6> <p>Weight loss interventions given for either less than 3 months or 3 months or more made little or no difference to dietary intake (<a href="./references#CD013119-fig-0055" title="">Analysis 5.4</a>). </p> </section> </section> <section id="CD013119-sec-0105"> <h5 class="title">Physical activity behaviours</h5> <p><a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> reported simple provision of advice and regular encouragement to increase levels of physical activity as part of a lifestyle intervention did not lead to improved physical activity behaviours compared to usual care. They reported no change in physical activity time for the intervention compared to the usual care group nor any difference between the two groups ability to meet Australian physical activity guidelines of 150 minutes of moderate intensity activity per week. </p> </section> <section id="CD013119-sec-0106"> <h5 class="title">Cost per disability‐adjusted life years or quality‐adjusted life years</h5> <p>None of the included studies reported cost per DALYs or QALYs events.</p> </section> <section id="CD013119-sec-0107"> <h5 class="title">Cost associated with weight loss intervention</h5> <p>None of the included studies reported on cost associated with weight loss interventions.</p> </section> <section id="CD013119-sec-0108"> <h5 class="title">Adverse events and potential harms</h5> <p>Five studies reported on adverse outcomes associated with their weight loss intervention. Adverse effects reported included depression and diarrhoea, hypotension, musculoskeletal injuries, and hospitalisations. No studies reported on biochemical adverse effects such as hyperkalaemia or hyperphosphataemia. </p> <p> <ul id="CD013119-list-0035"> <li> <p><a href="./references#CD013119-bbs2-0008" title="KannegantiVK , CollinsE , ButlerJ , O'ConnellS , JelinekC , McBurneyC , et al. Impaired physical fitness in obese diabetic patients with chronic kidney disease [abstract no: SA-PO368]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):710A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. American Journal of Nephrology2016;44(1):54-62. [MEDLINE: 27385652]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: 194]. American Journal of Kidney Diseases2016;67(5):A67. [EMBASE: 72313497]LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: FR-PO771]. Journal of the American Society of Nephrology2014;25(Abstract Suppl):545A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial (NCT01036490) [abstract no: TH-PO675]. Journal of the American Society of Nephrology2015;26(Abstract Suppl):244A. LeeheyDJ , CollinsE , KramerHJ , CooperC , ButlerJ , McBurneyC , et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial [abstract no: FR-PO830]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):558A. ">Leehey 2016</a> reported no study‐related adverse events in lifestyle (combined exercise and diet) group nor the diet only group. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0003" title="AlsouqiA , TaylorJM , EllisCD , BianA , StewartTG , Robinson-CohenC , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe CKD [abstract no: TH-PO444]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):214. [EMBASE: 633698382]AydemirN , PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , et al. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition Metabolism &amp; Cardiovascular Diseases2020;30(8):1375-81. [MEDLINE: 32571614]IkizlerTA , Robinson-CohenC , EllisC , HeadleySAE , TuttleK , WoodRJ , et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. Journal of the American Society of Nephrology2018;29(1):250-9. [MEDLINE: 29038285]PikeMM , AlsouqiA , HeadleySA , TuttleK , EvansEE , MilchCM , et al. Supervised exercise intervention and overall activity in CKD. KI Reports2020;5(8):1261-70. [MEDLINE: 32775825]TaylorJM , AlsouqiA , Robinson-CohenC , EllisCD , HeadleySA , TuttleKR , et al. Supervised exercise intervention and overall physical activity in individuals with moderate to severe CKD [abstract no: TH-PO520]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):234. [EMBASE: 633697678]">Ikizler 2018</a> reported seven study‐related adverse events with six of those happening in the aerobic exercise and caloric restriction group (atrial fibrillation requiring hospitalisation (1), hypotension due to weight loss (2), chest pain during exercise (1), musculoskeletal injuries (2)). A further episode of hypotension due to weight loss was reported in the usual activity and caloric restriction group. No study‐related adverse events were reported in the usual activity and usual diet group or in the aerobic exercise and usual diet group. </p> </li> <li> <p>Pharmacological interventions</p> <ul id="CD013119-list-0036"> <li> <p><a href="./references#CD013119-bbs2-0015" title="TomlinsonSA , LinesJG , GreenfieldMA . The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgraduate Medical Journal1975;51 Suppl 1:166-70. [MEDLINE: 768962]">Tomlinson 1975</a> reported fenfluramine had no effect of allograft function however some participants experienced diarrhoea and depression. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported orlistat was well tolerated in amongst participants, with few episodes of diarrhoea occurring during the first one to two months only and reported no incidence of AKI or oxalate nephropathy. </p> </li> </ul> </li> <li> <p>Surgical interventions</p> <ul id="CD013119-list-0037"> <li> <p><a href="./references#CD013119-bbs2-0016" title="TzvetanovI , D'AmicoG , GeorgievG , JeonH , Garcia-RocaR , BenedettiE , et al. Combined robotic kidney transplantation and sleeve gastrectomy in obese recipients: Initial results from prospective randomized study [abstract]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953189]">Tzvetanov 2015</a> reported no surgical or medical complications related to the combined bariatric surgery and kidney transplantation. Participants in the intervention arm presented with no difficulties in maintaining immunosuppression, as well as no episodes of acute cellular or antibody mediated rejection. </p> </li> <li> <p><a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> reported two hospital re‐admissions with dehydration within 30 days post‐surgery amongst participants who underwent sleeve gastrectomy. </p> </li> </ul> </li> </ul> </p> </section> </section> <section id="CD013119-sec-0109"> <h4 class="title">Subgroup analyses</h4> <p>We did not perform subgroups analyses for BMI (overweight versus obese), chief causes of CKD, (diabetes, hypertension, glomerulonephritis, polycystic kidney disease, reflux kidney disease) and presence or absence of proteinuria because there were not enough studies to estimate effects in these subgroups. </p> </section> <section id="CD013119-sec-0110"> <h4 class="title">Sensitivity analyses</h4> <p>We did not perform any sensitivity analyses because there were not enough studies included in the analyses. </p> </section> <section id="CD013119-sec-0111"> <h4 class="title">Assessment of reporting bias</h4> <p>We did not draw funnel plots due to limited number of studies per outcome.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013119-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013119-sec-0112"></div> <section id="CD013119-sec-0113"> <h3 class="title" id="CD013119-sec-0113">Summary of main results</h3> <p>This systematic review summarises 17 studies (988 participants) examining the effect of weight loss interventions (lifestyle, pharmacological and surgical) for the treatment of overweight and obesity in adults with CKD. Included studies had a median study duration of 12 months (range 5 weeks to 3 years). Majority of studies (13) examined lifestyle weight loss interventions (dietary, exercise and or dietary and exercise combined) compared to usual standard care or other dietary weight loss interventions. Only two small studies (17 participants) included surgical weight loss interventions. The included studies involved people with CKD stages 1 to 4 (n = 620) and kidney transplant recipients (n = 368). There were no studies that investigated weight loss interventions for people with ESKD requiring dialysis or those choosing supportive care management. Interventions and comparators varied across the included studies. The studies were separated into three main groups for comparison: Any weight loss interventions versus usual care or control (main comparator), any weight loss intervention versus dietary intervention, and surgical intervention versus non‐surgical intervention. The risk of bias in the included studies were often unclear or high, and when combined with considerable heterogeneity in weight loss interventions and imprecision in effect estimates, led to low or very low confidence in the results. </p> <p>None of the included studies were designed to evaluate the effects of weight loss interventions on death or cardiovascular events. As a result, whether weight loss interventions can lower the risk of death or cardiovascular events remains unanswered. This finding has important implications as people with all stages of CKD experience high levels of death and morbidity from CVD. </p> <p>Overall, weight loss interventions (involving predominately lifestyle interventions) were more successful than the usual care or control comparators in reducing body weight, however had uncertain effects for other anthropometric measures including BMI, waist circumference, waist‐to‐hip ratio, and measures of fat mass. The effect of any weight loss interventions (all studies were non‐surgical interventions) was not superior to dietary only intervention comparators for weight loss. One study looking at surgical intervention compared to non‐surgical intervention found a greater reduction in weight loss, BMI, waist circumference and fat mass than the combined lifestyle and pharmacological comparator. </p> <p>The effects of weight loss interventions on clinical measures across all comparators were infrequently measured limiting the ability of studies to be combined and reducing the overall quality of the evidence. Compared to usual standard care or control there were improvements in some, but not all clinical parameters. Improvements were found in LDL cholesterol; uncertain effects were found on CrCl, SCr, proteinuria, SBP, DBP, fasting blood glucose, HbA1c, and triglycerides; and no significant effect was found on total cholesterol, HDL cholesterol, and C‐reactive protein. There was limited reporting of adherence to treatment, adverse events, and potential harms across all three comparisons. The interventions that did report on these measures reported no major medical complications or serious adverse events with lifestyle, pharmacological or surgical weight loss interventions. A number of other secondary outcomes including successful kidney transplantation, nutritional status, biochemical adverse effects such as hyperkalaemia or hyperphosphataemia, cost associated with weight loss intervention, and cost effectiveness (per DALYs or QALY) were not measured in any of the included studies. Overall, the data from this review suggests that current evidence for weight loss interventions in overweight and obese individuals with CKD is limited and of very low to low quality and may be insufficient to guide clinical practice. </p> </section> <section id="CD013119-sec-0114"> <h3 class="title" id="CD013119-sec-0114">Overall completeness and applicability of evidence</h3> <p>This review examined 17 studies assessing the effects of lifestyle, pharmacological and surgical weight loss interventions in overweight and obese people with CKD. The strengths of the review include a comprehensive review of all types of weight loss interventions in CKD in both overweight and obese adults in all stages of CKD and limiting our review to RCTs and quasi‐RCTs. The majority of included studies involved lifestyle interventions with small numbers, with heterogeneous interventions and outcome measures, making comparison difficult. We could not assess the effect of weight loss interventions on important endpoints such as death or cardiovascular events, as none of the included studies in this review were designed to measure these outcomes. While all included studies reported on at least one anthropometric measure, there was inconsistent reporting for most clinical parameters, and limited to no reporting of patient‐centred outcomes, economic analysis and adverse events and potential harms. Due to within study heterogeneity we could not determine the effect of weight loss interventions on SCr and CrCl. There were four studies with mixed populations of CKD stages 1 to 4 (<a href="./references#CD013119-bbs2-0004" title="JesudasonDR , PedersenE , CliftonPM . Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts. American Journal of Clinical Nutrition2013;98(2):494-501. [MEDLINE: 23719550]">Jesudason 2013</a>; <a href="./references#CD013119-bbs2-0005" title="KittiskulnamP , KanjanabuchT , ChancharoenthanaW , PraditpornsilpaK , Eiam-ongS , TungsangaK . The beneficial effects of body weight reduction in overweight patients with proteinuric immunoglobulin A nephropathy: a randomized controlled trial [abstract no: FR-PO787]. Journal of the American Society of Nephrology2013;24(Abstracts):544A. [CENTRAL: CN-01657790] KittiskulnamP , KanjanabuchT , TangmanjitjaroenK , ChancharoenthanaW , PraditpornsilpaK , Eiam-OngS . The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin A nephropathy: a randomized controlled trial. Journal of Renal Nutrition2014;24(3):200-7. [MEDLINE: 24759301]">Kittiskulnam 2014</a>; <a href="./references#CD013119-bbs2-0010" title="MoralesE , ValeroM , LeonM , DiazO , Lopez-PardoC , VargasC , et al. Anitproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract]. Journal of the American Society of Nephrology2001;12(Program &amp; Abstracts):231A. [CENTRAL: CN-00446824] MoralesE , ValeroMA , HernandezE , LeonM , PragaM . Antiproteinuric effect of weight loss in obese patients with chronic proteinuric nephropathies [abstract no: M243]. Nephrology Dialysis Transplantation2002;17(Abstracts Suppl 1):117. [CENTRAL: CN-00550621] MoralesE , ValeroMA , LeonM , HernandezE , PragaM . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. American Journal of Kidney Diseases2003;41(2):319-27. [MEDLINE: 12552492]">Morales 2003a</a>; <a href="./references#CD013119-bbs2-0012" title="PragaM , HernandezE , AndresA , LeonM , RuilopeLM , RodicioJL . Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron1995;70(1):35-41. [MEDLINE: 7617115]">Praga 1995</a>) that included participants with hyperfiltration and reduced kidney function (eGFR) at baseline in the same treatment groups. These studies did not account for the different direction of change in which CrCl and SCr with weight loss in those with hyperfiltration (improvement via a reduction) versus those with a reduced eGFR (improvement via an increase). We found no differences in daily energy intake post intervention in lifestyle interventions versus usual care or control, as the majority of studies included in this sub‐analysis were exercise based interventions and did not prescribe a reduction in energy intake. Subgroup analyses were not able to be performed for many outcomes as often less than two studies reported the same outcome measures. Reporting on a set of core outcome measures for weight loss interventions in people with CKD would be helpful in future research studies to improve the quality of evidence. </p> <p>Only two studies with very small sample sizes reported on surgical interventions with limited reporting on our outcomes of interest. Therefore, the benefits reported in these surgical intervention studies must be confirmed in larger studies to improve the quality and certainty of evidence to better guide clinical practice. None of the included studies involved participants undergoing dialysis treatment or supportive care management. Therefore, the results from this review may not be generalisable to these population groups. Further studies are therefore warranted to examine the effects of weight loss interventions in these population groups. </p> </section> <section id="CD013119-sec-0115"> <h3 class="title" id="CD013119-sec-0115">Quality of the evidence</h3> <p>The overall certainty of evidence for reported outcomes was very low. We downgraded the evidence for uncertain or high risk of bias, inconsistency, indirectness, and imprecision. Meta‐analysis was also difficult due to inconsistent reporting of outcome measures and significant heterogeneity in the characteristics of interventions. Key methodological limitations including risk of bias led to downgrading of all evidence by one level (high to moderate). Methods for interventions were insufficiently reported by most studies. The relative impact of lifestyle intervention on most outcomes (aside from waist circumference) was downgraded due to moderate to high statistical heterogeneity, leading to low certainty of evidence. Weight management interventions varied widely, including diet, diet and physical activity, physical activity alone, diet and pharmacotherapy, and weight loss surgery. Furthermore the control or comparator interventions were also varied, making direct comparisons difficult. Finally, due to the small sample size and often small number of included studies the results were imprecise, further compounding the uncertainty of evidence. </p> </section> <section id="CD013119-sec-0116"> <h3 class="title" id="CD013119-sec-0116">Potential biases in the review process</h3> <p>Potential biases in this review relate to the data availability in the individual studies, and heterogeneity in treatment intervention and comparisons. Additionally, sensitivity analyses could not be performed and reporting bias could not be assessed due to the limited number of included studies. Finally, treatment endpoints were surrogate markers of health (proteinuria, SBP and DBP) and the effects of weight loss interventions on longer term outcomes such as death and cardiovascular events remains uncertain. Study authors were contacted to provide additional information in an attempt to reduce potential bias (see <a href="./appendices#CD013119-sec-0126">Appendix 3</a> for additional information requested and provided by authors). </p> <p>The strength of this review is that it included an up‐to‐date and comprehensive review of previous publications through a thorough MEDLINE, EMBASE and CENTRAL search and only included RCTs or quasi RCTs, as pre‐specified. Data extraction, data analysis and quality assessment were performed by two independent investigators, and any differences in consensus were checked with an additional author. It should be noted that there is potential conflict of interest as author HM was the principal investigator and co‐author of <a href="./references#CD013119-bbs2-0009" title="MaclaughinHL , HallWL , PatelAG , BlacklockRM , PhanishM , SwiftP , et al. Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 CKD: a randomised controlled pilot study [abstract no: O16]. In: UK Kidney Week; 2014 Apr 29-2 May; Glasgow, UK. 2014. MaclaughlinHL , HallWL , PatelAG , BlacklockRM , MacdougallIC . Kidney function, adipokines, and quality of life after weight loss surgery in obese patients with stages 3-4 chronic kidney disease: a randomized controlled pilot study [abstract no: FR-PO785]. Journal of the American Society of Nephrology2013;24(Abstract Suppl):543A. MacLaughlinHL , HallWL , PatelAG , BlacklockRM , SwiftPA , PhanishMK , et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. American Journal of Kidney Diseases2014;64(4):660-3. [MEDLINE: 25085646]">MacLaughlin 2014</a> study and KC is a co‐author of <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a> study both studies were included in this review. Authors MC, DJ, and KC work at the same facility where <a href="./references#CD013119-bbs2-0011" title="OrazioLK , IsbelNM , ArmstrongKA , TarnarskyjJ , JohnsonDW , HaleRE , et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. Journal of Renal Nutrition2011;21(6):462-71. [MEDLINE: 21454091]">Orazio 2011</a> and <a href="./references#CD013119-bbs2-0006" title="BeethamKS , HowdenEJ , IsbelNM , CoombesJS . Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease. BMC Nephrology2018;19(1):366. [MEDLINE: 30563479]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Effects of a 3-year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease [abstract no: 017]. Nephrology2015;30(Suppl 3):21. [EMBASE: 71995806]BeethamKS , HowdenEJ , KrishnasamyR , IsbelNM , CoombesJS . Feasibility of higher intensity exercise in patients with chronic kidney disease. Journal of Sports Medicine &amp; Physical Fitness2018;58(1-2):127-34. [MEDLINE: 27377256]FadaeeSB , BeethamKS , HowdenEJ , StantonT , IsbelNM , CoombesJS . Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. Redox Report2017;22(5):197-204. [MEDLINE: 27090392]HowdenEJ , CoombesJ , LeanoR , IsbelN , MarwickT . Effect of exercise and lifestyle intervention on LV and vascular function in patients with chronic kidney disease: a randomized controlled trial [abstract no: 3119]. European Heart Journal2012;33(Suppl 1):515. HowdenEJ , CoombesJ , PetcheyW , IsbelN . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: SA-OR376]. Journal of the American Society of Nephrology2011;22(Abstracts):90A. HowdenEJ , CoombesJS , StrandH , DouglasB , CampbellKL , IsbelNM . Exercise training in CKD: efficacy, adherence, and safety. American Journal of Kidney Diseases2015;65(4):583-91. [MEDLINE: 25458662]HowdenEJ , LeanoR , PetcheyW , CoombesJS , IsbelNM , MarwickTH . Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clinical Journal of the American Society of Nephrology: CJASN2013;8(9):1494-501. [MEDLINE: 23970136]HowdenEJ , LeanoR , PetcheyW , IsbelNM , CoombesJS , MarwickTH . A one-year lifestyle intervention improves myocardial function and exercise capacity in patients with chronic kidney disease [abstract no: 062]. Nephrology2011;16(Suppl 1):39-40. [EMBASE: 70532410]SmallDM , BeethamKS , HowdenEJ , BriskeyDR , JohnsonDW , IsbelNM , et al. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report2017;22(3):127-36. [MEDLINE: 28075321]SmallDM , BeethamKS , HowdenEJ , BriskyDR , JohnsonDW , IsbelNM , et al. Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease [abstract no: 049]. Nephrology2015;30(Suppl 3):30-1. [EMBASE: 71995838]">LANDMARK 3 2013</a> were undertaken. </p> </section> <section id="CD013119-sec-0117"> <h3 class="title" id="CD013119-sec-0117">Agreements and disagreements with other studies or reviews</h3> <p>Our finding of a decrease in BMI with dietary interventions compared to control or usual care agree with a previous systematic review reporting pooled results from studies of non‐dialysis CKD and in participants with hyperfiltration (<a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a>). Other systematic reviews of outcomes of weight loss interventions in CKD populations did not report pooled effects, however all included studies demonstrated significant decreases in body mass or BMI within intervention groups but did not compare weight or BMI differences between groups (<a href="./references#CD013119-bbs2-0035" title="AfshinniaF , WiltTJ , DuvalS , EsmaeiliA , IbrahimHN . Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrology Dialysis Transplantation2010;25(4):1173-83. [MEDLINE: 19945950]">Afshinnia 2010</a>; <a href="./references#CD013119-bbs2-0037" title="BolignanoD , ZoccaliC . Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrology Dialysis Transplantation2013;28 Suppl 4:iv82-98. [MEDLINE: 24092846]">Bolignano 2013</a>). </p> <p>The effect of weight loss interventions on proteinuria was uncertain in lifestyle interventions and was not reported in studies of surgical interventions. This contrasts with previous findings reported by <a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a>, and <a href="./references#CD013119-bbs2-0035" title="AfshinniaF , WiltTJ , DuvalS , EsmaeiliA , IbrahimHN . Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrology Dialysis Transplantation2010;25(4):1173-83. [MEDLINE: 19945950]">Afshinnia 2010</a>, with significant reductions in proteinuria. However both studies pooled only within group differences for intervention groups from observational studies and controlled studies and did not include comparisons with controls. This indicates that contrary to findings from observational studies, weight loss may not induce a reduction in proteinuria with moderate weight loss achieved with lifestyle interventions. However, one study included in the meta‐analysis compared diet induced weight loss with captopril, and found both equally effective at reducing proteinuria, which increases the bias towards a null finding. We found no change in albuminuria, and this is supported by the findings of <a href="./references#CD013119-bbs2-0037" title="BolignanoD , ZoccaliC . Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrology Dialysis Transplantation2013;28 Suppl 4:iv82-98. [MEDLINE: 24092846]">Bolignano 2013</a> who reported two RCTs with no change in albuminuria, and a reduction in proteinuria or albuminuria in observational studies. </p> <p>Measures of creatinine did not change with weight loss in either lifestyle or surgical interventions. This is similar to the findings of <a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a> and <a href="./references#CD013119-bbs2-0061" title="Van HuffelL , TomsonCR , RuigeJ , NistorI , Van BiesenW , BolignanoD . Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review. PLoS ONE [Electronic Resource]2014;9(11):e113667. [MEDLINE: 25423489]">Van Huffel 2014</a>, also reporting no change in these measures with weight loss. We were unable to evaluate the effect of weight loss on measured GFR. Measured GFR was examined in two studies with low protein diet treatment arms, and showed a small improvement, however one of these studies did not achieve weight loss, limiting the applicability of the findings to the effects of intentional weight loss. Low density lipoprotein cholesterol decreased and the effect of weight loss on total cholesterol and triglycerides was uncertain. <a href="./references#CD013119-bbs2-0054" title="NavaneethanSD , YehnertH , MoustarahF , SchreiberMJ , SchauerPR , BeddhuS . Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2009;4(10):1565-74. [MEDLINE: 19808241]">Navaneethan 2009</a> reported a decrease in total cholesterol with weight loss, and no change in HDL cholesterol or triglycerides within weight loss treatment groups. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013119-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013119-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013119-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013119-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 1: Mean weight loss [kg] or post intervention body weight" data-id="CD013119-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 1: Mean weight loss [kg] or post intervention body weight </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 2: Body mass index" data-id="CD013119-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 2: Body mass index </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 3: Waist circumference" data-id="CD013119-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 3: Waist circumference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 4: Waist‐to‐hip ratio" data-id="CD013119-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 4: Waist‐to‐hip ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 5: Creatinine clearance [points]" data-id="CD013119-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 5: Creatinine clearance [points] </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 6: Serum creatinine" data-id="CD013119-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 6: Serum creatinine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 7: Proteinuria" data-id="CD013119-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 7: Proteinuria </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 8: Systolic blood pressure" data-id="CD013119-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 8: Systolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 9: Diastolic blood pressure" data-id="CD013119-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 9: Diastolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 10: HbA1c" data-id="CD013119-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 10: HbA1c </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 11: Fasting glucose" data-id="CD013119-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 11: Fasting glucose </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 12: Total cholesterol" data-id="CD013119-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 12: Total cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 13: LDL cholesterol" data-id="CD013119-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 13: LDL cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 14: HDL cholesterol" data-id="CD013119-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 14: HDL cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 15: Triglycerides" data-id="CD013119-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 15: Triglycerides </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 16: C‐reactive protein" data-id="CD013119-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 16: C‐reactive protein </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any weight loss intervention versus usual care or control, Outcome 17: Dietary energy intake" data-id="CD013119-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Any weight loss intervention versus usual care or control, Outcome 17: Dietary energy intake </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 1: Mean weight loss [kg] or post intervention body weight" data-id="CD013119-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 1: Mean weight loss [kg] or post intervention body weight </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 2: Body mass index" data-id="CD013119-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 2: Body mass index </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 3: Waist circumference" data-id="CD013119-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 3: Waist circumference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 4: Waist‐to‐hip ratio" data-id="CD013119-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 4: Waist‐to‐hip ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 5: Creatinine clearance [mL/min/1.732]" data-id="CD013119-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 5: Creatinine clearance [mL/min/1.73<sup>2</sup>] </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 6: Proteinuria" data-id="CD013119-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 6: Proteinuria </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 7: Measured GFR" data-id="CD013119-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 7: Measured GFR </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 8: Systolic blood pressure" data-id="CD013119-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 8: Systolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 9: Diastolic blood pressure" data-id="CD013119-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 9: Diastolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 10: HbA1c" data-id="CD013119-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 10: HbA1c </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 11: Fasting blood glucose" data-id="CD013119-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 11: Fasting blood glucose </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 12: C‐reactive protein" data-id="CD013119-fig-0032" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 12: C‐reactive protein </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 13: Total cholesterol" data-id="CD013119-fig-0033" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 13: Total cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 14: LDL cholesterol" data-id="CD013119-fig-0034" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 14: LDL cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 15: HDL cholesterol" data-id="CD013119-fig-0035" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 15: HDL cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 16: Triglycerides" data-id="CD013119-fig-0036" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 16: Triglycerides </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 17: Dietary energy intake" data-id="CD013119-fig-0037" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 17: Dietary energy intake </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 18: Quality of life: SF36 physical domain" data-id="CD013119-fig-0038" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 18: Quality of life: SF36 physical domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 19: Quality of life: SF36 mental domain" data-id="CD013119-fig-0039" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 19: Quality of life: SF36 mental domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-002.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 20: Quality of life: CES‐D" data-id="CD013119-fig-0040" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-002.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2: Any weight loss intervention versus dietary intervention, Outcome 20: Quality of life: CES‐D </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-002.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 1: Mean weight loss (change score)" data-id="CD013119-fig-0041" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 1: Mean weight loss (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 2: Body mass index" data-id="CD013119-fig-0042" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 2: Body mass index </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 3: Waist circumference (change score)" data-id="CD013119-fig-0043" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 3: Waist circumference (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 4: Body composition: fat mass (change score)" data-id="CD013119-fig-0044" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 4: Body composition: fat mass (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 5: Proteinuria (change score)" data-id="CD013119-fig-0045" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 5: Proteinuria (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 6: Serum creatinine (change score)" data-id="CD013119-fig-0046" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 6: Serum creatinine (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 7: C‐reactive protein (change score)" data-id="CD013119-fig-0047" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 7: C‐reactive protein (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 8: Quality of life: SF36 physical domain (change score)" data-id="CD013119-fig-0048" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 8: Quality of life: SF36 physical domain (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 9: Quality of life: SF36 mental domain (change score)" data-id="CD013119-fig-0049" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: Surgical versus non‐surgical weight loss intervention, Outcome 9: Quality of life: SF36 mental domain (change score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Weight loss intervention versus usual care or control: stage of CKD, Outcome 1: Mean weight loss [kg or %]" data-id="CD013119-fig-0050" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Weight loss intervention versus usual care or control: stage of CKD, Outcome 1: Mean weight loss [kg or %] </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Weight loss intervention versus usual care or control: stage of CKD, Outcome 2: Total cholesterol" data-id="CD013119-fig-0051" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Weight loss intervention versus usual care or control: stage of CKD, Outcome 2: Total cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 1: Mean weight loss: post intervention body weight" data-id="CD013119-fig-0052" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 1: Mean weight loss: post intervention body weight </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 2: Body mass index" data-id="CD013119-fig-0053" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 2: Body mass index </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 3: Total cholesterol" data-id="CD013119-fig-0054" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 3: Total cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013119-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/urn:x-wiley:14651858:media:CD013119:CD013119-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 4: Dietary energy intake" data-id="CD013119-fig-0055" src="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_t/tCD013119-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Weight loss intervention versus usual care or control: duration of intervention, Outcome 4: Dietary energy intake </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/media/CDSR/CD013119/image_n/nCD013119-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013119-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any weight loss intervention compared to usual care or control</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Any weight loss intervention versus usual care/control for weight loss in people with chronic kidney disease (CKD) who are overweight or obese</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with CKD who are overweight or obese<br/><b>Setting:</b> various (hospital outpatient clinic, research organisation)<br/><b>Intervention:</b> any weight loss intervention<br/><b>Comparison:</b> usual care or control </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with usual care/control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with weight loss intervention</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (any cause)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported by any of the included studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported by any of the included studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Weight loss</b><br/>Follow up: range 5 weeks to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean weight loss ranged across control groups from 0.3 to 0.7 kg; mean post intervention body weight ranged from 86 to 136 kg </p> <p>The mean weight loss in the intervention group was 3.69 kg lower than the control group (5.82 lower to 1.57 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>180 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Majority of studies from lifestyle interventions</p> <p>No studies involving surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Body mass index (BMI)</b><br/>Follow up: range 3 to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean BMI across control groups ranged from 28 to 38 kg/m²</p> <p>The mean BMI in the intervention group was 2.18 kg/m² lower than the control group<br/>(4.90 lower to 0.54 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Waist circumference</b><br/>Follow up: range 3 to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean waist circumference across control groups ranged from 96 to 103 cm</p> <p>The mean weight circumference in the intervention group was 0.68 cm lower than the control group (7.6 lower to 6.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proteinuria</b><br/>Follow up: range 3 to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean proteinuria across control groups ranged from 0.5 to 3.5 g/day</p> <p>The mean proteinuria in the intervention group was 0.29 g/day lower than the control group (0.76 lower to 0.18 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Systolic blood pressure (SBP)</b><br/>Follow up: range 3 to 6 months </p> <p><b>Diastolic blood pressure (DBP)</b><br/>Follow up: range 3 to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean SBP across control groups ranged from 123 to 140 mmHg</p> <p>The mean SBP in the intervention group was ‐3.45 mmHg lower than the control group (‐9.99 lower to 3.09 higher) </p> <p>The mean DBP across control groups ranged from 75 to 89 mmHg</p> <p>The mean DBP in the intervention group was ‐2.02 mmHg lower than the control group (‐3.79 lower to 0.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>139 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All of studies from lifestyle interventions</p> <p>No studies involving pharmacological or surgical interventions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Evidence certainty downgraded one level for indirectness </p> <p><sup>2</sup> Evidence certainty downgraded one level for imprecision </p> <p><sup>3</sup> Evidence certainty downgraded one level for uncertain or high risk of bias </p> <p><sup>4</sup> Evidence certainty downgraded one level for moderate heterogeneity </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any weight loss intervention compared to usual care or control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/full#CD013119-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013119-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any weight loss intervention versus usual care or control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Mean weight loss [kg] or post intervention body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.69 [‐5.82, ‐1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Lifestyle: dietary interventions (post intervention body weight)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.73 [‐16.06, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Lifestyle: physical activity (post intervention body weight)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.32 [‐27.45, 14.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Lifestyle: mixed interventions (mean weight loss)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐4.33, ‐0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Pharmacological interventions: appetite suppressant (mean weight loss)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.53 [‐5.33, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.18 [‐4.90, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.36 [‐5.68, ‐1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [‐1.90, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Waist circumference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐7.60, 6.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.60 [‐12.88, 3.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [‐4.45, 9.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Waist‐to‐hip ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Lifestyle: mixed interventions (change score)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Creatinine clearance [points] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [‐0.34, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐0.11, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐1.80, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Serum creatinine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.52, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.62, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐0.27, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Proteinuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.76, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.15, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.46, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.90 [‐13.75, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐7.90, 3.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.28 [‐30.93, 8.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.49 [‐11.13, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.59 [‐17.43, 6.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.95 [‐14.78, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐1.15, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐3.84, 4.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Lifestyle: mixed interventions (change score)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐1.17, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Fasting glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.27 [‐2.66, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.20 [‐17.04, 27.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Lifestyle: mixed interventions (change score)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐2.69, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.06 [‐20.30, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.99 [‐31.29, 5.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.00 [‐34.97, 18.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.3 Lifestyle: mixed interventions (change score)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.70 [‐25.58, 10.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.4 Pharmacological interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.10 [‐45.10, 73.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 LDL cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.30 [‐16.70, ‐3.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.28 [‐16.47, 23.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.00 [‐38.05, 8.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.3 Lifestyle: mixed interventions (change score)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.60 [‐18.68, ‐4.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 HDL cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.3 Lifestyle: mixed interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐24.61 [‐49.53, 0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.29 [‐65.23, 32.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐46.00 [‐163.90, 71.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.3 Lifestyle: mixed interventions (change score)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐32.40 [‐39.58, ‐25.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 C‐reactive protein <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Dietary energy intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐1.35, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Lifestyle: dietary interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.77 [‐2.70, ‐0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 Lifestyle: physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.73, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.3 Lifestyle: mixed interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.86, 0.45]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any weight loss intervention versus usual care or control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013119-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any weight loss intervention versus dietary intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Mean weight loss [kg] or post intervention body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [‐2.12, 3.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Low carbohydrate diet versus Mediterranean diet (post intervention body weight)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [‐6.23, 10.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Low fat diet versus Mediterranean diet (post intervention body weight)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [‐5.69, 11.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Moderate‐protein weight loss diet versus Standard‐protein weight loss diet (mean weight loss) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [‐3.30, 9.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.4 Dietary advice + appetite suppressant (pharmacological) versus dietary advice alone (mean weight loss) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐4.61, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.27 [‐4.43, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐1.97, 2.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐1.86, 2.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.80 [‐6.22, ‐3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.4 Energy restriction + exercise versus energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐4.65, 3.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Waist circumference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Waist‐to‐hip ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Creatinine clearance [mL/min/1.73<sup>2</sup>] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Proteinuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Measured GFR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.25, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Low protein weight loss diet + keto‐amino acids versus Low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.42, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Energy restricted low protein diet versus energy restricted moderate protein diet </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐0.24, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.33 [‐8.32, 3.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [‐5.94, 8.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.23 [‐8.25, 5.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.3 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.00 [‐10.57, ‐5.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.4 Energy restriction + exercise versus dietary energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.00 [‐8.57, 16.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.87 [‐3.59, ‐0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐5.61, 4.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.49 [‐6.72, 3.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.3 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐4.09, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.4 Moderate protein weight loss diet versus standard protein weight loss diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.00 [‐8.55, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.62 [‐3.87, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 Energy restriction + exercise versus energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.73, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.2 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.70 [‐3.45, ‐1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Fasting blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.56 [‐10.21, 5.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐11.27, 10.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.71 [‐15.35, 5.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 C‐reactive protein <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.1 Energy restriction + exercise versus energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 Total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.01 [‐21.38, 17.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.49 [‐11.10, 30.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐24.13, 22.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.3 Low protein weight loss diet + keto‐amino acids versus low protein weight diet alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐23.20 [‐33.95, ‐12.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.4 Energy restriction + exercise versus energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.00 [‐6.75, 38.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.5 Dietary advice + appetite suppressant (pharmacological) versus dietary advice alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐18.00 [‐94.25, 58.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.14 LDL cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [‐16.66, 19.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.31 [‐12.91, 27.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.60 [‐15.88, 25.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.3 Low protein weight loss diet + keto‐amino acids versus low protein weight diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.34 [‐32.58, ‐6.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.4 Energy restriction + exercise versus energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.00 [‐4.87, 44.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.15 HDL cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.80 [‐8.71, ‐0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.69 [‐9.11, 3.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.09 [‐12.04, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.3 Energy restriction + exercise versus energy restriction alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.00 [‐13.98, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.16 Triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.22 [‐31.50, 25.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.1 Low carbohydrate diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [‐49.06, 60.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.2 Low fat diet versus Mediterranean diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐46.75, 47.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.3 Low protein weight loss diet + keto‐amino acids versus low protein weight diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐23.20 [‐37.84, ‐8.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.4 Energy restriction + exercise versus energy restriction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>49.00 [‐17.63, 115.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.17 Dietary energy intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.1 Energyrestricted low protein versus energy restricted moderate protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.18 Quality of life: SF36 physical domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.1 Energy restriction + exercise versus energy restriction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.19 Quality of life: SF36 mental domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.19.1 Energy restriction + exercise versus energy restriction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.20 Quality of life: CES‐D <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.20.1 Energy restriction + exercise versus energy restriction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any weight loss intervention versus dietary intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013119-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Surgical versus non‐surgical weight loss intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Mean weight loss (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.43 [‐13.58, ‐7.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Waist circumference (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Body composition: fat mass (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Proteinuria (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Serum creatinine (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 C‐reactive protein (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Quality of life: SF36 physical domain (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 Quality of life: SF36 mental domain (change score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Surgical versus non‐surgical weight loss intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013119-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Weight loss intervention versus usual care or control: stage of CKD</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Mean weight loss [kg or %] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐4.53, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 CKD stages 1‐5: (mean weight loss) [kg]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐8.79, 6.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Transplant: (mean weight loss) [%]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐4.42, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.92 [‐27.31, 3.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 CKD stages 1‐5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.02 [‐30.02, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Transplant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.10 [‐42.26, 70.46]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Weight loss intervention versus usual care or control: stage of CKD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013119-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Weight loss intervention versus usual care or control: duration of intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Mean weight loss: post intervention body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.65 [‐4.54, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Intervention duration ≤ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐4.73, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Intervention duration &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐5.66, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.49 [‐4.97, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Intervention duration ≤ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [‐3.59, 4.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Intervention duration &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.36 [‐5.68, ‐1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.65, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Intervention duration ≤ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.85, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.2 Intervention duration &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.76, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Dietary energy intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐1.88, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Intervention duration ≤ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.72, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.2 Intervention duration &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.14 [‐2.50, 0.23]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Weight loss intervention versus usual care or control: duration of intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013119.pub2/references#CD013119-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013119.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013119-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013119-note-0013">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013119-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013119-note-0011">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD013119-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD013119-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013119-note-0012">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD013119-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013119-note-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013119-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013119\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013119\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013119\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013119\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013119\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013119.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013119.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013119.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013119.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013119.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727246338"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013119.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727246342"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013119.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea76049fa9365',t:'MTc0MDcyNzI0Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 